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ABSTRACT 
Using the piglet as a model for the human infant, the goal of this study was to compare 
dietary lipid matrices found in infant formula and maternal milk on post-natal 
neurodevelopmental patterns. Over a 25-day feeding study, piglets (n=9-10 per treatment, 1.5 ± 
0.2 kg initial BW) were either sow-reared (SR) with ad libitum intake, or artificially-reared (AR) 
receiving 1 of 3 milk replacers modified to mimic the nutritional profile and intake pattern of 
sow’s milk. Our AR treatments included: T1, artificially-reared (AR) control formula; T2, T1 + 
45% total dietary fat replaced with pre-digested fat (PDF); T3, T2 + 10% lecithin + 0.4% 
cholesterol. Sow-reared animals were used as a positive control for study outcomes. Piglets were 
weighed daily, serum samples were collected at d 0, d 14, and d 25 of study, and fecal samples 
were collected, and pooled from d 13-27. At 3 weeks of age, piglets were subjected to a 
standardized set of magnetic resonance imaging (MRI) procedures to identify macro- and micro-
structural characteristics of the brain. At study conclusion, piglets were euthanized and tissues 
were collected for further analysis. For the duration of the study, SR piglets exhibited higher BW 
gain and heavier extracted whole brain weights compared with AR piglets. Analysis of fecal fat 
suggested greater (P < 0.05) excretion of dietary fat with addition of PDF along with lecithin and 
cholesterol. Serum lipid profiling at d 14 and d 25 of study revealed serum triglycerides (TAG) 
concentrations to be higher (P = 0.176, P = 0.164) in T3-fed piglets when compared with T1- 
and T2-fed piglets. Furthermore, serum cholesterol concentrations were higher (P < 0.05) in T3-
fed piglets when compared with T1- and T2-fed piglets on d 25 of study. Furthermore, 
hippocampal tissue analysis revealed neutral lipid (NL) docosahexaenoic acid (DHA) 
concentrations were greater (P < 0.05) in T3-fed pigs compared with T1-fed and SR pigs. 
Hippocampal phospholipid (PL) DHA concentrations of T2- or T3-fed pigs were intermediate to 
T1-fed and SR piglets. Diffusion tensor imaging, a MRI sequence that characterizes brain 
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microstructure, revealed that SR piglets had greater (P < 0.05) average whole-brain fractional 
anisotropy (FA) values compared with AR piglets, suggesting differences in white matter 
organization. Although global analysis did not reveal differences within AR treatments for DTI 
outcomes,  FA values of the internal capsule were not different between SR and T3-fed piglets, 
suggesting a modulatory effect of PDF + lecithin + cholesterol fat system on white matter 
maturation. Higher fecal fat excretion, partnered with higher serum TAG concentrations in T3-
fed piglets as compared with other AR treatments, suggested higher bioavailability of the PDF 
when supplemented with lecithin and cholesterol. Elevated serum cholesterol at d 25 of study, 
partnered with elevated hippocampal DHA concentrations of T3-fed animals suggested higher 
bioavailability of the PDF, especially when supplemented with lecithin and cholesterol. Higher 
FA values in the internal capsule of T3-fed piglets indicate higher myelination of this early 
maturing white matter rich region as compared with other AR treatments, and may be impacted 
by elevated serum cholesterol concentrations. As the animal matures in age, the 2-fold elevation 
of hippocampal DHA seen in T3-fed piglets, as compared with control or SR animals, may 
produce similar elevations white matter maturation in the hippocampus as seen in the IC. 
Overall, our results indicate differential patterns of white matter development between AR and 
SR animals, and replacing part of formula TAG with PDF, and addition of lecithin and 
cholesterol, may elicit preferential accretion of brain DHA due to compositional manipulations 
of the dietary lipid matrix. 
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Chapter 1 
INTRODUCTION 
Breast milk is considered the “gold standard” for infant nutrition with its unique nutrient 
macro and micronutrient composition. Although designed to meet the nutrient requirements of 
neonate, commercially available infant formulas are frequently reformulated as ongoing research 
elucidates a more complete characterization of maternal milk. One such area of research focuses 
on the variability between the dietary lipid matrix found in infant formula, and that of breast 
milk. There are notable differences in cholesterol and polyunsaturated fatty acid composition as 
well as structural incorporation of these factors within the dietary triacylglycerol and 
phospholipids in infant formula when compared with breast milk (1). Lipids constitute 50-60% 
dry weight of the mammalian brain, with n-3 and n-6 fatty acids accounting for 30-35% of total 
brain fatty acids (2). Accretion of docosahexaenoic acid (DHA), the most abundant n-3 fatty acid 
of the central nervous system, has been shown to be 2 fold higher in breast-fed infants when 
compared with formula-fed infants (3). Consumption of preformed DHA has been reported to be 
negatively correlated with neurodevelopmental disorders (4), improve structural and functional 
maturity of neurons (5), and enhanced cognitive abilities in early life (6). As DHA is a natural 
component of breast milk, a large body of epidemiological literature hypothesizes this n-3 fatty 
acid drives the differential neurodevelopmental trajectories observed in breast-fed and formula 
fed infants (1,7,8). Characterization of the role of DHA in infant neural maturation has gained 
momentum in the recent past, yet few studies have focused on the incorporation, metabolism and 
bioavailability of long chain polyunsaturated fatty acids in infant formula and maternal milk. 
The broad goal of this thesis is to identify nutrient-related strategies to alter the lipid 
matrix found in infant formula to allow for greater incorporation of DHA in the brain. Due to 
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ethical concerns surrounding the use of human infants for such research, we employed the 
neonatal piglet that has previously been established in nutritional neuroscience research (9–11). 
Clinically relevant magnetic resonance imaging (MRI) techniques were used to assess macro and 
microstructural maturation of the brain, as well as hippocampal neurochemical concentrations in 
both formula-reared and sow reared piglets. Characterization of the neurodevelopmental patterns 
of the sow-reared piglet allowed for the establishment of a conspecific positive control for the 
artificially-reared piglet model, similar to the relationship of the breast-fed infant to the formula-
fed infant. Finally, erythrocyte and hippocampal DHA concentrations, whole body growth 
performance, maturation of the intestinal epithelium, and circulating lipid profiles were assessed 
to further understand the impact of modifying the dietary lipid matrix on lipid metabolism of the 
neonate and incorporation of LCPUFA into neural tissue. 
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 Chapter 2 
 
LITERATURE REVIEW 
 
Nutrient Composition of Breast Milk 
Breast milk as gold standard for human infant nutrition 
Complete with a comprehensive macro- and micro-nutrient panel, and nonnutritive 
bioactive components, breast milk (BM) is often labeled the ‘gold standard’ for human infant 
nutrition. The World Health Organization recommends 6 months of exclusive breast feeding for 
infants, as it has long been associated with increased survival and optimal growth and 
development of the infant. Of particular significance are the large body of observational and 
cognitive studies have correlated exclusive or mixed breast feeding to the optimal development 
of the infant brain and increased intelligence quotients in adolescence and adulthood (1,2).  
Nutritional quality of human BM is highly conserved across different populations with 
average macronutrient content of term milk approximating at 0.9-1.2 g/dL protein, 3.2-3.6 g/dL 
fat, and 6.7-7.8 g/dL lactose. Whey and casein primarily make up the protein fraction of BM, 
along with other components including α-lactalbumin, lactoferrin, secretory immunoglobulin A 
(IgA), and others. Lactose is the principal sugar present, but is complimented by 
oligosaccharides that possess a bioactive effect on the developing organism (3). Breast milk is 
also high in palmitic and oleic acids that are esterified to the sn-2 and sn-1 or 3 positions, 
respectively, of the glycerol backbone of dietary fat. In addition to the macronutrient 
components, BM also contains bioactive components and growth factors that aid in the 
development of multiple organ systems. Some examples of these include epidermal growth 
factor (EGF), brain derived neurotropic factor (BDNF), and glial cell derived neurotropic factors 
(GDNF), which aid in growth of the enteral nervous system, and multiple immunological factors 
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aiding in the transfer of immunity from mother to child (3). Overall, BM allows for the transfer 
of a plethora of compounds from the mother to child that are not currently present in artificial 
infant formula.   
Lipid Fraction of Human Breast Milk 
In recent years, the impact of BM lipids on the development of the neonatal brain has 
been heavily studied (1,4,5). Maternal milk fat not only provides up to 50% of the infant’s 
caloric intake, but also serves as a building block for the complex and rapid development 
experienced during infancy (6). Triacylglycerols (TAG) provide approximately 98% of total fat, 
and is considered the major lipid fraction in BM. Cholesterol, hydrocarbons, sterol esters, 
diacylglycerols, monoacylglycerols, free fatty acids, sterols and phospholipids constitute the 
remaining subset of dietary fat found in human BM (7).  
Breast milk TAG are unique not only in terms of the lipid composition, but also in the 
structural integration of n-3 and n-6 poly unsaturated fatty acids (PUFA) and their precursors. 
The short chain predecessors of these PUFA, α-linolenic acid (ALA; 18:3 n-3) and linoleic acid 
(LA; 18:2 n-6), are considered essential fatty acids (EFA), and must be obtained from dietary 
sources due to mammalian incapacity for endogenous synthesis (8,9). These fatty acids play a 
vital role in the maturation of the rapidly proliferating central nervous system of the infant. In 
adults, an intake of EFA at 3-6% of total dietary fat is recommended for normal biological 
function, with provisions of ALA at 0.5-1% of total fat intake also required for the integrity of 
neuronal and visual tissues (10). The most common dietary sources of ALA are green leaves, 
linseed, canola, flaxseed and walnut oils as well as fish such as herring, salmon and tuna. In 
addition to fatty fish, LA can be acquired from corn, sunflower and safflower oils, pork, walnuts, 
peanuts, and wheat products (11–13). The most biologically active metabolites of these essential 
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fatty acids are docosahexaenoic acid (DHA; 22:6 n-3), eicosapentaenoic acid (EPA; 20:5 n-3), 
and arachidonic acid (ARA; 20:4 n-6) (14). Alpha-linolenic acid and LA serve as precursors to 
their metabolites through the action of delta-6 desaturase, elongation, delta-5 desaturation and β-
oxidation in the PUFA biosynthetic pathway (Figure 2.1). 
Docosahexaenoic acid has been increasingly promoted as a long-chain (LC) PUFA 
essential to neural development in infancy. Incorporation of DHA in the infant diet has been 
associated with increased brain DHA accretion (15), improved development of myelinated white 
matter (16), visual acuity (17) and cognitive development (18). To assess the impact of DHA on 
visual and cognitive development, BM and RBC DHA was quantified, and segmented into high, 
middle and low categories. Of these infants, those possessing the lowest concentration of RBC 
phosphatidylethanolamine (PE) DHA at 60 days of age, were found to have lower visual acuity 
at 1 year when compared with subjects with high RBC PE DHA concentration. Language 
development at 9 and 18 months of age were also altered due to BM DHA status when 
environmental, maternal and infant variables known to effect development were taken into 
account (19). Moreover, DHA supplementation during both gestation and lactation elicited 
higher mental processing scores in children at 4 years of age as assessed by sequential 
processing, simultaneous processing, and non-verbal abilities (20). Considering the significant  
rate of brain development that occurs during the perinatal stages, insufficient intake of DHA may 
lead to alterations in neurogenesis and neurotransmitter metabolism, resulting in suboptimal 
cognitive performance in the developing infant (21). Feeding a DHA deficient diet during the 
perinatal period has been shown to be detrimental to cognitive development, including deficits in 
learning and memory paradigms including the Morris water maze and passive avoidance tasks in 
mice (22). These DHA-deprived mice were able to partially recover reference and working 
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memories when supplemented with DHA-rich fish oil. In contrast, control animals fed chow 
supplemented with DHA showed significant increases in both memory types (22). These data 
from human and animal research suggest DHA is a key dietary FA required to ensure proper 
development of the infant brain. In order to further understand the impact of DHA on infant 
brain development, it is essential to identify and assess the ideal concentration, and structural 
inclusion of DHA in dietary fat, whether it is provided in infant formula or BM.  
Human BM concentrations of DHA correlate with maternal dietary intake of PUFA. 
Average DHA content of breast milk varies across countries and geographic regions, but North 
American, European and Australian populations average at DHA concentration of 0.2-0.3 g/100g 
total FA (14,23,24). Areas of the world, such as Japan, where consumption of seafood rich in 
DHA is high, BM DHA concentrations average at 1.0 g/100 g total FA (25).  Daily average 
intake of DHA at 200 mg/d during lactation can allow for accretion of BM DHA at 0.30-0.35% 
of total milk fats (26). To meet these requirements, approximately one 3.5 oz. serving of fatty 
salmon or 10 non-fatty fish should be consumed on a weekly basis (27). Under circumstances in 
which breast feeding is not possible, the World Association of Perinatal Medicine recommends 
0.2-5% of total fat provisions to be obtained from DHA (26). 
Breast-fed infants experience whole body DHA accretion at approximately 10 mg/d in 
the first 6 months of life. Approximately half of this whole-body gain is represented within the 
brain at 5.0 mg/d during this time period. Once consumed, there is an estimated 50-60% 
obligatory loss of consumed DHA to carbon recycling to de novo synthesis of saturated and 
monounsaturated FA, cholesterol synthesis and oxidation (28). Considering the high amount of 
obligatory loss, 20 mg of DHA must be consumed daily to maintain accretion status seen with 
breast fed infants. Assuming average milk intake of 750 mL/d with DHA content at 0.2% of total 
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FA, breast fed infants consume 60 mg of DHA per day, which is well above the required 20 
mg/d (28).  Although endogenous synthesis of DHA from ALA is possible, the conversion rates 
are often lower than what is necessary to obtain DHA accretion similar to that of the breast-fed 
infant. Baboon infants provided with commercially available formula devoid of DHA, but 
supplemented with ALA and LA at a ratio of 1:10, experienced conversion rates of ALA to DHA 
at  9% of human infant requirements (29). In rats, conversion rates are slightly higher at 1.4% or 
27% of human infant requirement. These data suggest supplementation of preformed DHA is a 
viable strategy to manipulate the fat matrix, and may allow for absorption of DHA to be similar 
to that of maternal milk. 
The Impact of Structure and Composition of Dietary Fat Matrix on Absorption 
Of the vast array of saturated fatty acids present in human BM, palmitic acid (16:0) 
composes 20-25% of milk fatty acids. The structural  incorporation of palmitic acid into BM 
TAG is unique in structure and composition (12). Approximately 70% of palmitic acid found in 
milk TAG is esterified at the sn-2 position. A higher proportion of BM palmitic acid is absorbed 
compared with cow milk or infant formula which preferentially esterifies palmitic acid at sn-
1and sn-3 positions (7,30).  Palmitic acid positioned at the latter positions are hydrolyzed by 
pancreatic lipase, while sn-2 esterified FA remain as 2-monoacylglycerol. This pre-determined 
hydrolysis pattern dictates the importance of positional distribution of FA for the sake of 
bioavailability. Alterations of to these specific positional specificity of palmitic acid results in 
calcium soaps, which subsequently impedes both fat and calcium absorption in the infant gut 
(31). Palmitic acid has a melting point well above body temperature (63°C), and combines with 
calcium and other divalent cations at intestinal pH to generate soaps (30). Incorporation of sn-2 
esterified palmitic acid in infant formula reduces stool concentration of palmitic acid and 
 9 
 
increases stool softness compared with control formulas (30). These data suggest greater 
absorption of palmitic acid and lower calcium excretion as indicated by softer stool. Similarly, 
DHA and other LCPUFA are primarily esterified to sn-1 and sn-3 positions in BM (12), and is 
cleaved by pancreatic lipase to allow for optimal absorption. Overall, the combined activity of 
lipases and the positional specificity of FA esterification plays a critical role in fat digestion and 
absorption in infancy. 
Although the role of DHA on infant development has obtained notoriety in the literature 
over recent years, few studies focus on identifying dietary strategies which allow for tissue 
incorporation of DHA at levels similar to that found in breast fed infants. Presently there are 
three sources of delivery of DHA in human foods including infant formula: triacylglycerols 
(TAGs), phospholipids (PL), or ethyl esters (32). These TAG sources of DHA are predominantly 
generated from microalgae, and PL source extracted from egg yolk.  Although the absolute 
quantity of DHA accretion in tissue is higher with TAG, DHA accretion in the brain has been 
determined to be more efficacious, when provided in the PL (32). Although the percentage of fat 
absorption has been reported to be higher with the incorporation of PUFA with PL rather than 
TAG (33), other studies have shown no differences in DHA absorption between piglets fed DHA 
in TAG form compared with DHA supplemented as egg-yolk PL (34). Liu et al. found absolute 
gray matter and synaptosome DHA concentrations to be higher when provided in TAG form, but 
DHA accretion, as a % of dosage, to be significantly higher when provided as PL (32). 
Considering this conflicting evidence, it is essential that the role of dietary PL in DHA 
absorption is characterized to enable to allow for optimal incorporation of DHA in the 
developing brain.  
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Dietary Fat Metabolism in Human Infants 
Hydrolysis of Dietary Fat 
Absorption and post-processing of dietary lipids can be summarized in four steps which 
include hydrolysis, absorption, intracellular processing, and export of dietary fat into lymphatic 
circulation. Hydrolysis of milk triglycerides is a highly efficient process carried out through the 
sequential actions of gastric lipase, colipase-dependent pancreatic lipase (pancreatic lipase), bile 
salt-dependent lipase (BSDL, i.e., carboxyl esterase lipase), and bile salt-stimulated lipase 
(BSSL) (35–37).  Preferential action of gastric lipase on the sn-3 position of dietary TAG 
primarily initiates the hydrolysis of dietary fat. The high level of stereo specificity found in 
human BM dictates that major milk unsaturated fats including oleic acid (18:1 n-9) and linoleic 
acid (18:2 n-6) are esterified at these outer 1 and 3 positions, generating 1,2-diacylglycerol and 
3-monoglyceride (12,38,39). Mediated by pancreatic lipase, hydrolysis of TAG continues in the 
duodenum to further hydrolyze 1,2-diacylglycerol into 2-monoacylglycerol (2-MAG) and 2 free 
fatty acids (FFA) (31,40).  
Though pancreatic lipase levels are low in infancy in comparison to a fully developed 
digestive system, the BM-fed infant is able to efficiently metabolize high concentrations of 
dietary fat (41). This considerable difference in hydrolysis capacity is reinforced through the 
activity of BSDL derivative, BSSL, that is also present in BM. Bile salts secreted by the liver and 
dispensed by the gall bladder acts as an emulsifier for the lipid components entering the small 
intestine, allows for larger surface area for lipase activity and mediates micelle formation to 
transport monoacylglycerols and FA into the enterocyte.  
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Absorption and Post Processing 
 Protein-independent and protein-dependent diffusion models have been proposed as 
mechanisms of transport of LCFA across the apical membrane of the enterocyte (42). Due to its 
lipophilic nature, FA are presumed to diffuse through the apical membrane, but multiple proteins 
of interest have been identified as long chain FA transporters across the plasma membrane of the 
enterocyte (42,43). First identified in mice, fatty acid translocase (FAT) and the human analog 
CD36, are known to be a highly expressed protein of interest for FA transport (44). The 
expression of FAT/CD36 is significant in tissues exposed to large concentrations of FA, and is 
up regulated in the presence of high dietary fat (45). Another apical membrane protein with high 
affinity for LCFA transport is fatty acid binding protein (FABP), which has been identified in the 
brush border membrane. Fatty acid uptake can be inhibited with the use of FABP binding 
antibodies in mice, thus revealing its role in LCFA absorption into the enterocyte (Stremmel, 
Lotz, Strohmeyer, & Berk, 1985). The fatty acid transport protein 4 (FATP4) is predominantly 
expressed in the mammalian gut and has been hypothesized to be responsible for the intracellular 
trapping of FA by esterification with coenzyme A (CoA) (48,49). Although the mechanism 
behind FA absorption into the enterocyte is not fully characterized, it is likely that passive 
diffusion and active transport jointly moderate the high level of fat absorption that occurs in the 
intestine.  
Re-esterification and Transport  
Re-esterification of TAG post-absorption into the enterocyte occurs through 2 major 
pathways, the glycerol-3-phosphate (G-3-P) and 2-MAG pathways, and one minor pathway, the 
dihydroxyacetone phosphate pathway (Figure 2.2). Sequential acetylation of G-3-P to sn-1, 2 
diacylglycerol via the activity of G-3-P acyltransferase and the acylation of sn-2 MAG via the 
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acyl-CoA:monoacylglycerol acyltransferase (MGAT) activity generates diacylglycerol (DAG). 
Diacylglycerol is then converted to TAG by acyl CoA:diacylglycerol acyltransferases (12). Of 
the three pathways that are present, the 2-MAG pathway serves as the primary route of re-
synthesis and accounts for 70-80% of TAG regeneration (50). 
Following re-esterification, dietary lipids are incorporated into chylomicrons and secreted 
into the mesenteric lymphatic system. Chylomicrons, being the largest and least dense of the 
lipoprotein family [less than 0.95g/ml, 100-500 nm in diameter], are composed of a hydrophilic 
phospholipid monolayer, with a hydrophobic core containing  cholesterol esters and TAG (51). 
Formation of chylomicrons occurs in a two-step process. First, apolipoprotein B48, 
phospholipids, apolipoprotein A-IV, cholesterol and TAG combine to generate a high density 
particle called the primordial chylomicron. In the second step, this primordial chylomicron 
combines with a TAG and cholesterol ester mass (that does not feature Apo B48) to form the 
pre-chylomicron, which is subsequently transported to the cis-Golgi. During the first step of 
lipoprotein biogenesis, microsomal triglyceride transfer protein (MTP), possessing lipid transfer 
activity, adds newly synthesized TAG to the Apo B48 and primordial chylomicron complex (42). 
Subsequent to addition of Apo A-IV and stabilization of the phospholipid and cholesterol 
monolayer, prechylomicrons are then exported from the endoplasmic reticulum to the cis-Golgi 
via prechylomicron transport vesicles (52).  The complex is further modified in the golgi, and 
ultimately undergoes exocytosis into the lymphatic system and is transported to the liver via the 
thoracic duct and subclavian vein (31).  
The Role of DHA in Neurodevelopment  
The modulatory effects of DHA on a variety of physiological and disease states have 
been thoroughly investigated (53–57). Although the molecular basis of these effects have not 
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been fully characterized, DHA has been shown to play a significant role in eicosanoid 
production, formation of peroxidation products, conformation and activity of enzymes, 
transcription of proteins and plasma membrane integrity (58). Of particular interest is the 
incorporation of DHA in the rapidly proliferating neuronal membrane of the infant cerebrum, 
and its unique ability to impact structure-induced functions of neurons and resulting alternations 
in the neuronal integrity and learning potential of developing infants. 
Of the many physical properties of membranes affected by PUFA status, the most 
fundamental impact may be on membrane fluidity, or disorder and rates of molecular 
reorientation experienced by the plasma membrane. Naturally-occurring DHA-rich membranes, 
such as neuronal tissue and the outer segment of retinal photoreceptors, are reported to be highly 
fluid, which begs the question of whether a diet-induced increase in membrane fluidity is 
possible. Consumption of DHA deficient diets has been shown to cause substantial decreases in 
DHA incorporation and membrane fluidity (59). Although dietary supplementation of DHA has 
revealed increased membrane fluidity in animal models consuming fish oil diets high in DHA, 
others have not been able to reproduce such results (58,60,61). However, increases in fluidity 
were observed in “modeled” membranes using steady-state fluorescence, with significant 
increases with the addition of the first double bond and further increases in fluidity up to the 
addition of  four double bonds (62). More sensitive methods have revealed an increase in lateral 
fluidity, indicating that physiologically-relevant changes in membrane fluidity may be present in 
the whole animal due to dietary incorporation of DHA. These changes may be more subtle, yet 
still relevant, in the physiological membrane.  
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Structure Impacting Function: n-3 PUFA and Modulation of Learning and Memory  
Compositional differences in neuronal membranes due to DHA status may not only 
impact structural components, but also alter functional aspects of the neuron, including signal 
conduction and transmission and neurochemistry. Diet-induced changes in lipid composition of 
neuronal membranes can compromise the propagation of electrical signals, and also inhibit 
chemical signaling between neurons due to depletion of vesicle-stored neurotransmitters. 
Changes to plasma membrane integrity alters neuronal responses to acetylcholine, a 
neurochemical responsible for arousal, attention, and learning and memory. Impaired attention 
and learning behavior have been reported in chronically n-3 PUFA-deficient rodents during 
shock avoidance tasks, olfactory learning and exploratory behavior. In these animals, 
hippocampal release of acetylcholine was 34% lower than in control animals, however basal 
levels of acetylcholine in the hippocampus remained high when compared with control animals 
(63). Elevated basal levels present in deficient animals have been hypothesized to be a result of 
the compositional difference in glycerophospholipid incorporation of DHA and a resulting 
depletion of vesicle-stored neurotransmitters (63). 
Dopaminergic neurotransmission, often associated with motivation and attention, have 
also shown to be altered in n-3 PUFA deficiency. Rats fed an n-3 PUFA-supplemented diet 
possessed 40% higher levels of dopamine in brain tissues, accompanied by a significant decrease 
in monoamine oxidase activity in the frontal cortex compared with animals fed a control diet 
(64). In the case of n-3 PUFA deficiency, endogenous release of vesicle-stored dopamine 
decreased upon stimulation. Behavioral parameters were also negatively impacted, as evidenced 
by increased interaction of deficient animals with the environment (65). The authors 
hypothesized that the low vesicular pool of dopamine reduced the impact of positive reward and 
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provided greater disruption of learning (66,67). Overall, diet-induced changes in DHA 
concentration of neuronal membranes can results in structural, functional and behavioral 
outcomes that can negatively impact learning potential of the organism. 
The role of n-3 PUFA in maintaining integrity and function of the plasma membrane is 
evident, but the impact of these alterations on potential for learning is of high importance in the 
human infant. Polyunsaturated FA deficiency of the n-3 variety has been shown to impair 
hippocampal-dependent learning, which includes encoding of spatial information and spatial task 
memory (68). Although molecular mechanisms behind the impact of DHA deficiency on 
learning behavior are not fully understood, the role of structural components on learning 
behavior are evident as the structural content of the hippocampal neuron directly correlates to 
arborization of hippocampal neurons (11). 
Dietary supplementation of DHA has an impact on long-term potentiation (LTP) and 
long-term depression, which are two forms of synaptic plasticity involved in learning and 
memory. Depolarization of the post-synaptic membrane, and the subsequent release of 
neurotransmitters into the synaptic cleft, allows for LTP formation. Post-synaptic release of 
arachidonic acid in vivo following depolarization of the pre-synaptic membrane modifies 
neurotransmitter release from the pre-synaptic membrane and subsequently amplifies LTP (69). 
Not only is the intracellular release of DHA crucial for LTP formation, the presence of 
extracellular DHA in vitro has also been observed to block the induction of long-term depression 
in hippocampal CA1 neurons (70). In vivo studies have also shown a negative correlation, with 
decreased DHA level corresponding to increased total latency in the behavioral task, for mice 
subjected to diet-induced deficiency of DHA (71). Such evidence, in combination with the 
presence of smaller hippocampal neurons in DHA-deficient mice, indicates that a period of n-3 
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FA deficiency in early development may induce structural impairments to irreversibly impact 
learning behavior in animal models (72).  
Although direct assessment of cognitive outcomes is difficult to ascertain in humans, 
direct measurement of the impact of DHA supplementation on brain activity through functional 
MRI protocols are available. They have revealed a dose-dependent increase in functional activity 
in the dorsolateral prefrontal cortex and precentral gyrus during a continuous performance or 
attention task compared with placebo groups (73), suggesting a modulatory effect of DHA 
supplementation on functional cortical activity and attention. Prolonged supplementation of 
DHA along with long chain n-6 FA have been show to alleviate cognitive and behavioral 
problems in children diagnosed with dyslexia and attention deficit hyperactivity disorder (74). 
Collectively, these data suggest that DHA has the potential to impact learning at a fundamental 
level and ameliorate symptoms associated with neurological disorders impacting learning and 
behavior.  
Incorporation of Polyunsaturated Fatty Acids into Neural Tissue 
Lipid Components of the Neural Membrane 
The lipid-rich neural membrane comes second only to adipose tissue in terms of its 
incorporation of a complex variety of lipid species. These molecules include neutral lipids, 
phospholipids, and other lipid fractions, in total representing approximately 50-60% of total 
brain mass. The neutral lipid fraction alone includes cholesterol, cholesterol esters, FFA, MAG, 
DAG, and TAG. The phospholipid subset includes glycerophospholipids, the most abundant of 
which include phosphatidylcholine (PCH); phosphatidylethanolamine (PE); phosphatidylserine 
(PS); and phosphatidylinositol (PINS), along with sphingomyelin, and phosphatidic acid. The 
remaining lipid fraction incorporates cardiolipins, cerebrosides and gangliosides (75). In 
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neuronal tissue, DHA is primarily incorporated in the synaptosomal glycerophospholipids of the 
plasma membrane, with the largest proportion being integrated into PS and PE (76–78). 
Docosahexaenoic acid, along with other LCPUFA, are found primarily esterified to the sn-2 
chain of the glycerol backbone of glycerophospholipids, while the sn-1 position is often occupied 
by a saturated FA, such as palmitic or stearic acids. The positional distribution of these PUFA 
enable the neuron to maintain structural integrity, membrane fluidity, and thereby allow for 
optimal function of receptors, membrane bound proteins and ion channels.  
Turnover and Biosynthesis of DHA in Neural Tissue 
Polyunsaturated FA, including DHA, are critical structural components of neuronal and 
glial cell membranes. Primarily esterified to the phospholipids of neuronal tissue, DHA 
experiences rapid diurnal turnover (79). Despite rapid regeneration, a predominant fraction of 
DHA is recycled back into phospholipids with the aid of a variety of enzymes including multiple 
isoforms of phospholipase A2. The cerebral endothelium and astrocytes interact to generate 
DHA from precursors including eicosapentaenoic acid, docosapentaenoic acid and ALA, and 
release the converted compounds to the extracellular medium. Incapable of in vivo synthesis, 
neuronal cells rely on the cohesive action of endothelial cells and astrocytes to generate and 
dispense DHA into the extracellular medium, from where it is ultimately obtained by neurons 
(13). Uptake of precursors or pre-formed DHA from circulation is regulated by the neuronal 
endothelium, also known as the blood brain barrier (BBB).  
Model for Transport of FA in to Neurons 
Multiple models of fatty acid transport across the selectively-permeable BBB have been 
outlined in the literature (80,81). Circulating FA are generally found in the following forms: 
unesterified, esterified to PL, cholesterol, and TAG components of lipoproteins, or covalently 
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bound to erythrocytes and platelets. Fatty acids with 22 carbons or less are primarily (~99%) 
bound to albumin, while FA of longer chain lengths are preferentially bound to lipoproteins (79). 
The role of albumin-mediated transport of DHA into the brain is generally agreed upon, yet the 
question of whether simple diffusion or protein-mediated transport regulates the entry of FA into 
the endothelium remains a topic of debate (81,82). Although a small amount of lipoprotein 
hydrolysis occurs in the capillaries, uptake of whole lipoproteins into the brain does not occur, 
therefore lipolysis and generation of unbound FA is the first step in lipid absorption in the brain 
(83). Considering approximately 5% of albumin-bound FA is “stripped” in a single passage, a 
unifying model of transmembrane movement of FA incorporation into the brain is often 
proposed (80,84). Diffusion and protein-mediated transport is combined in this model, with FA 
binding to the luminal surface of the endothelial membrane and unionized forms of FA diffusing 
across the endothelial cytoplasm. Because BBB cells are narrow (~0.1 µm), the flip-flop process 
of diffusion repeats, thereby allowing FA diffusion across the transluminal membrane of the 
endothelium and into the brain. Selective esterification mediated by FATP traps the optimal 
variety of FA inside the neuron, and allows for further downstream processing (80). Other 
models of transmembrane movement of FA suggest that selective discrimination for preferred 
FA occurs directly within the endothelial cell. In this model, receptor-mediated absorption of 
whole lipoproteins are followed by intracellular lipolysis and protein-mediated transport of FA 
into the brain. Proposed transporter proteins include monocarboxylic acid transporters (MCT) 
and FATP to mediate the selective transluminal transport of FA into adjacent astrocytes (82). 
Due to possible regulation at multiple points, including lipoprotein hydrolysis and protein 
synthesis, the latter model is less consistent with the rapid incorporation of circulating FA. 
However, it does account for the high selectivity observed in FA incorporation into the brain.  
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Once absorbed into the brain, unesterified FA are converted into fatty acyl-CoA (FA-
CoA) in order to retain these FA within the cell. Through the action of acyltransferases, FA are 
then predominantly incorporated into phospholipids, which are considered the most stable lipid 
fraction. A smaller portion are shuttled to an alternate pathway, and undergo β-oxidation to 
maintain energy requirements of the brain (Figure 2.3) (79). Approximately 65% of radiolabeled 
DHA is maintained in the phospholipid fraction with 37% being attached to the sn-2 position of 
PE (84), suggesting a greater role of n-3 PUFA in structural components of the brain, rather than 
in energy maintenance.  
Nutritional Influences on Gastrointestinal Development 
Structural Development of the Intestinal Epithelium 
The intestinal epithelium is a critical interface between the gut lumen and intestinal tissue 
that regulates the absorption of dietary nutrients and macromolecules necessary to support rapid 
brain development in early life. Macro- and micronutrients, along with non-nutritive bioactive 
factors found in BM, are not only absorbed through the intestinal epithelium, but also facilitate 
further development of this organ system in preparation for weaning, immunological 
development and establishment of normal gastrointestinal (GI) function. The intestinal 
epithelium consists of finger-like villi and crypts from which enterocytes that line the villi 
originate. Varying forms of early-life nutrition can impact development of the structural 
components of the intestine. Infants who are predominantly breast-fed have smaller villi and 
crypts, but experience higher levels of crypt fission or division when compared to their formula-
fed counterparts (85). Similar to the morphology observed in the intestinal epithelium of weaned 
subjects, hyperplasia of existing crypts are the principal mode of gut maturation seen with 
formula feeding (85). The crypt fission model of intestinal development is associated with 
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growth of the small intestine and may be responsible for laying the foundation for maximum 
generation of feeder crypts to be present before hyperplasia and further development begin.  
Impact of Early Life Nutrition on Intestinal Structure and Function 
A classic measure of intestinal maturity in neonates is the development of standard 
patterns of disaccharidase activity. Differences in extent of structural and functional aspects of 
gut maturity may profoundly impact absorption, transport and delivery of essential glucose and 
lipids to the brain, ultimately resulting in alterations in customary patterns of brain development. 
There are two primary classes of disaccharides which include β-glycosidase (i.e., lactase) and α-
glucosidases (e.g., sucrase-isomaltase, maltase-glucoamylase, and trehalase) (86). In addition to 
the differences in structure, functional characteristics of intestinal development including 
disaccharidase activity are impacted by varying forms of infant nutrition. Evidence in alterations 
of functional growth can be seen in rat studies in which pups fed rat milk substitute exhibiting 
sucrase activity that were 20 to 45 times greater than dam-raised, control animals (87). In an 
effort to accurately compare the impact of experimental diets on brain maturation, the impact of 
both artificial formula and BM on disaccharidase activity must be assessed.   
Dietary fats, yielding the greatest number of calories per unit mass, are a major energy 
source for the animal, but they are also an important component for establishing cell membrane 
integrity in the brain (88). Long chain PUFA, namely ARA and DHA, constitute nearly 30% of 
the total FA in grey matter of the developing brain, and serve as essential components of neuron 
myelination and neuron outgrowth (89,90). Considering importance of the lipid fraction in 
energy maintenance and physiological development, it is no surprise that upwards of 90% of 
total dietary fat is absorbed in a term infant (36). In neonatal piglets, supplementation of n-3 
PUFA alters the mucosal architecture with a 38% decrease in intestinal villi length, bringing the 
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developing gut in line with morphology observed in organisms that are breast-fed (91). In 
addition, postnatal n-3 LCPUFA supplementation of DHA and EPA enhances the expression of 
GLUT-2 in the jejunum, allowing for greater glucose absorption (92). Such alterations in the 
architecture of the mucosal epithelium suggest the possibility of suboptimal whole-body and 
neural development as a result of consuming maternal milk substitutes not supplemented with n-
3 FA. It also presents an opportunity for further research into nutrient-based strategies to alter the 
lipid matrix of infant formula, allowing for optimal absorption of these beneficial LCPUFA. 
Patterns of Brain Development of the Term Infant 
Establishment of the Central Nervous System 
Neurodevelopment commences during gestation with the establishment of the neural 
tube, followed by emergence of the 3 primitive brain regions possessing functional specificity in 
the adult brain. The most rostral part of the neural tube evolves into the prosencephalon, which 
later develops in to the cortex, basal ganglia, limbic system, thalamus and hypothalamus, while 
the mesencephalon, or the mid brain, develops from the mid part of the neural tube. The most 
caudal region of the neural tube develops in to the rhombencephalon, or hindbrain, which 
contains the cerebellum, pons, and medulla of the adult brain (93). Following primary 
neurulation, further development of the central nervous system (CNS) continues with neuronal 
proliferation, migration, differentiation, synaptogenesis, organization, and myelination of axonal 
tracts (93,94). Although this developmental process is presented as a sequence of individual 
events, they actually overlap and extend into postnatal life. The latter period of postnatal 
neurodevelopment consist of dendrite development, lengthening of axons, elaboration of 
synaptic density and myelination (95). These critical neurodevelopmental events increase brain 
volume at a rapid rate in the days and months following birth, with overall brain volume 
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increasing to 64% of adult brain weight by 3 months of age (96). Considering the rapid rate and 
scope of these processes, infants are particularly vulnerable to nutritional insults during this 
sensitive period of early neurodevelopment.   
Postnatal Neurodevelopment 
Neuronal development in the months following birth consists of a diverse number of 
events including dendritic and axonal growth, synaptogenesis, differentiation and proliferation of 
glial cells, and subsequent myelination of axonal tracts. These events coincide with synaptic 
pruning and apoptosis, generating an interplay of progressive and regressive events that establish 
the neuronal network of the infant brain. Dendritic development accelerates in the last trimester 
of pregnancy and continues to be highly active up to the first year of postnatal life (97). In the 
first 6 months of life, axonal and dendrite length increases up to 10-fold (95) and dendritic 
arborization makes significant strides in laying the foundation for increases in synaptic density. 
Synaptic density increases at a variable rate depending on the functional hierarchy of needs of 
the infant. For example, the auditory and visual cortexes experience maximum synaptic density 
at approximately 3 months of age, while the prefrontal cortex reaches maximum density at 15 
months of age (98,99). The expedited rate of development in the visual and auditory areas speak 
to the importance of establishing the ability to see and hear, while the delay in the prefrontal 
cortex indicates that higher level thinking and decision making processes are less important in 
these early stages of development. Synaptogenesis and pruning precedes myelination, which is 
considered one of the classic neurodevelopmental events of postnatal life.   
The myelin sheath is composed of tightly packed plasma membrane of the glial subtype, 
namely oligodendrocytes in the CNS.  It encloses axons to insulate electrical signals and to 
maximize their conduction velocity, and allows for saltatory conduction of action potentials. Of 
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the two forms of glial cells that originate from the neuroepithelial cells of the neural tube, the 
microglial subset gives way to the oligodendrocytes that form the myelin sheath and astrocytes 
that are hypothesized to aid in the transport of myelin progenitors to their destination (100).  
Myelination of the central nervous system begins at approximately 25 weeks in utero and 
proliferates at high intensity in the first 6 months of postnatal life, continuing well into adulthood 
(101). The mature oligodendrocyte, which generates the complex structure of myelin, wraps 
around axonal tracts. It encompasses myriad proteins, including myelin basic proteins (MBP), 
proteo-lipid proteins , myelin associated glycoproteins and lipids including cholesterol, 
phospholipids, galactocerebrosides, and others (102). The mechanisms that initiate or regulate 
myelination are still under investigation, but the process has revealed itself to be highly ordered 
(94). It begins with the generation of oligodendrocyte precursors from the neural tube and their 
subsequent migration to the areas undergoing white matter development (103). Upon reaching 
their destinations, pre-oligodendrocytes proliferate extensively in white matter, and mature in the 
myelination phenotype. Myelination in the brain follows a predictable caudorostral 
directionality, and follows 5 general rules in regard to the order of pathway development: 1) 
proximal before distal, 2) sensory before motor, 3) projection before associative, 4) central sites 
before cerebral poles, and 5) occipital poles before frontal and temporal poles (94). Mature 
myelin forms in the motor tracts by 3 months of postnatal life, in frontal lobes by 5-6 months, in 
the paracentral regions and occipital poles by 15 months, and in the temporal regions by 23 
months of postnatal life (104). Due to the pervasive nature and rapid generation during early life, 
myelination represents an area of neurodevelopment that is highly vulnerable to nutritional 
insults (105).  
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Unlike most biological membranes, myelin is composed of predominantly lipids (70-
85%) with a lower concentration of proteins (15-30%), resulting in a lipid-enriched membrane 
(106). Myelin is enriched in a variety of lipid moieties, the most prominent of which include 
cholesterol, phospholipids and galactolipids at a ratio ranging from 4:3:2 to 4:4:2 (106,107). 
Myelin is particularly enriched in cerebrosides (a type of galactolipid), which contain a ceramide 
core that is rich in LCPUFA of chain lengths greater than 20 carbons (108). Cerebrosides showed 
a significant increase in LCPUFA incorporation (3 mg/d) between 3 and 11 d of age, and a 
continued increase in LCPUFA incorporation through 6 months of age. In addition, PE is a 
significant component of myelin membranes, as this phospholipid increases 15-fold from infancy 
to adulthood (75). Considering these data, it is evident that incorporating of LCPUFA such as 
DHA in the infant diet is imperative in this period of rapid neurodevelopment and elevated 
vulnerability to nutrient deficiencies.  
Magnetic Resonance Imaging Techniques to Assess Brain Development 
Introduction 
Magnetic resonance (MR) imaging (MRI) techniques allow for characterization of 
neurodevelopmental patterns and timelines in vivo. It permits the collection of quantifiable 
information on the macrostructure and microstructure, nutrient and neurotransmitter 
concentrations, and metabolism of the developing brain. Magnetic resonance imaging also 
allows for discrimination between white matter (WM), grey matter (GM), and cerebrospinal fluid 
(CSF), all of which serve as markers of neurodevelopment.  
Magnetic Resonance Imaging  
Magnetic resonance imaging relies on the magnetic properties of hydrogen atoms found 
in abundance in biological tissues. Protons of an atom possess a natural spin or precess, resulting 
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in an electrical current that in turn generates a magnetic field. The magnetic field generated by 
the precessing proton can be broken down in to x, y and z components with vectors representing 
the magnitude and direction of the magnetic field. When exposed to an external magnetic field, 
the intrinsic angular momentum of the nuclei will align in parallel and in anti-parallel with the 
external magnetic field. The parallel and antiparallel spins neutralize the field in the x and y 
components, but the magnetic field in the z direction sums in the direction of the external 
magnetic field to generate longitudinal magnetization (109). During excitation, the protons jump 
to a higher energy state, the longitudinal magnetization (z component) decreases, and transverse 
magnetization (x-y component) increases. During the relaxation phase, electromagnetic energy is 
retransmitted and is thus dubbed the nuclear MR signal. The time required for longitudinal 
magnetization to recover post-excitation is called longitudinal relaxation time, or T1, while the 
time required for transverse magnetization to disappear is referred to as transversal relaxation 
time, or T2 (109). The contrast mechanisms in MRI rely on the manipulations of T1 and T2 
phases. An additional parameter manipulated for image quality is repetition time (TR) of the 
excitatory radio frequency (RF) pulses, and the echo time (TE), which refer to the time period 
between excitation and data acquisition (110). For images acquired in the T1 phase, 
manipulations of TR allow for a gradient in the intensity of the resulting image. For example, a 
short TR image with a short T1 is highly sensitive to fat and brain tissue vs. CSF, and is highly 
useful in clinical setting where tissue masses (such as a tumor) need to be visualized. T2-
weighted images are manipulated by TE and allows for fluid such as CSF or edemas to be 
expressed at highest intensity. For our purposes, T1-weighted sequences are used to generate 
macrostructural datasets, while T2-weighted sequences are employed to image microstructural 
and neurochemical datasets.  
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Diffusion Tensor Imaging 
Diffusion tensor imaging (DTI) is an MRI modality that characterizes the organization 
and structural integrity of the axonal tracts of the brain. It originates from diffusion weighted 
imaging (DWI), which assesses the rate of diffusion of water molecules in the axonal 
microenvironment (111). Diffusion properties associated with DWI rely on Brownian motion of 
water molecules characterized by randomized, isotropic movement of free water molecules 
(112). Due to the presence of cell and organ structures, molecular level diffusion in biological 
tissues does not experience the same arbitrary movement observed in room temperature water. 
Changes in tissue composition can impact the rate and directionality of water diffusion, 
ultimately providing contrasts in MR images that allows for quantitative assessment of 
development. For instance, with increasing myelination of neuronal tissue, the diffusion of water 
molecules are restrained down the length of the white matter tracts rather than across them (104). 
Diffusion tensor imaging measures this diffusion of water and its directionality with respect to 
the axonal tract, allowing for an indirect measure of the level of myelination present in a given 
voxel.  
There are four quantitative measures used in DTI to assess free water diffusion in WM, 
and these measures collectively indicate the degree of WM development and myelination. Mean 
diffusivity (MD), axial diffusivity (AD), radial diffusivity (RD), and fractional anisotropy (FA) 
all provide distinct information regarding WM integrity, and these complementary measures are 
interdependent in accurately assessing brain development (111). Apparent diffusion is obtained 
from the calculated apparent diffusion coefficient (ADC) of free water molecules in the voxels, 
or 3-dimensional (3D) pixels, which comprise the MR image. In an ADC map, the intensity of 
each voxel reflects the level of resistance experienced by the free water, with higher ADC values 
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reflecting water movement down the organ structure and lower ADC values suggesting greater 
resistance due to a physical barriers (113). Mean diffusivity is an account of the averaged ADC 
from 6-30 orientations within axonal tracts, and represents a holistic picture of water diffusivity 
in the brain (111). Axial diffusivity and RD diffusion rates represent diffusion along and across a 
fiber orientation, respectively, as components of MD. Fractional anisotropy values quantify 
directionality of randomly moving water molecules in numerical values ranging from 0-1 
(113,114). Values closer to 1 indicate anisotropic movement and greater insulation of free water 
molecules, and provides an indirect, yet sensitive, means of assessing WM development (115). 
Although these values are powerful tools individually, they are more often used jointly. When 
combined with high FA and AD values, lower ADC values are often associated with an increase 
in cell density, indicating dense axonal packing, large axonal diameter and high myelination; all 
which correlate with mature WM.  
Magnetization-Prepared Rapid Gradient Echo 
Magnetization-prepared rapid gradient echo (MPRAGE) is a T1-weighted, 3D sequence 
of the gradient echo imaging technique, and provides macrostructural and anatomical 
information of the developing brain. This sequence can generate greater contrast between WM, 
GM and CSF in the brain and other organ systems than preceding T1-weighted spin-echo 
sequences (116,117). Structural sequences take advantage of the differences in T1 and T2 
relaxation periods of WM, GM and CSF to obtain variations in signal intensities which 
ultimately allows for the segmentation of these components. Generally, tissues with a rapid 
recovering T1 phase are depicted at higher intensity in structural datasets and slower recovering 
tissues having a lower intensity, and therefore possess a darker color. Typically, T1 relaxation 
times follow the following trend: fat > brain tissue, WM > GM, GM > CSF (Figure 2.3) (110). 
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Voxel-based morphometry (VBM) analysis of GM and WM volumes on a voxel-by-voxel basis 
are also obtained from the MPRAGE sequence. The potential for VBM data is immense as it can 
be tabulated or represented visually to outline GM and WM volume differences across the brain 
on a voxel-by-voxel basis, rather than pre-defined structural comparisons (118). In addition to 
VBM, region-specific volumes can be calculated from the MPRAGE sequence after warping 
individual datasets against a standardized atlas, and quantifying the variations due to treatment 
using an inverse warping sequence (119). Recent developments have allowed for the generation 
of a brain atlas that characterize the automated segmentation of MRI data sets for the emerging 
biomedical piglet model (119).  
Magnetic Resonance Spectroscopy 
Markers of structural integrity,  metabolic efficiency and energy status can be assessed in 
vivo through magnetic resonance spectroscopy (MRS) (120). Unlike the MPRAGE sequence, 
which provides morphometric and anatomical information, MRS generates a representation of 
the chemical makeup of the developing brain (121). Magnetic resonance spectroscopy provides a 
frequency analysis, or a fourier transform, of the signal detected. The line spectra provides 
frequency of a given metabolite in parts per million (PPM) and the strength of the signal as 
indicated by the height of the peak (Figure 2.4) (122). Whole-brain or single-voxel spectroscopy 
(SVS) measures can be attained, but the latter is region-specific and suppresses the signal from 
outside areas. Suppression of the water peak is another practice used to obtain a more refined and 
clear depiction of the neurochemicals that are detected with MRS (122). Most commonly 
reported metabolites include N-acetylaspartate (NAA), myo-inositol (INS), choline-containing 
compounds [i.e., acetylcholine (ACH), free choline (CHO), glycerophosphocholine (GPC) and 
phosphochoine (PCH), phosphatidylcholine (PC)], glutamine (GLN), glutamate (GLU), and 
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creatine-containing compounds [i.e., creatine (CR) and phosphocreatine (PCR)]. The 
physiological roles of these metabolites are integral in normal function and development of the 
brain.  
The Piglet as a Biomedical Model for the Human Infant 
Introduction 
Animal models serve as invaluable tools to assess the impact of nutrition on 
physiological development. Generally, rodents predominate in biomedical research, but small 
mammals, pigs, companion animals and non-human primates are also used. Physiological 
similarities to the human, ethical concerns and cost of upkeep are often evaluated when 
establishing the model for any type of research. In the field of nutritional neuroscience, evidence 
suggests the piglet may be the most appropriate species due to its status as a precocial 
“agrimedical” model, and due to its similarities in anatomy, physiology and metabolism as 
compared with the human (123,124). Parallels in neurodevelopmental patterns to the human 
infant, and the ability to be trained in behavioral tasks, allow for the neonatal piglet to be an 
appropriate model in assessing the impact of early-life nutrition on neurodevelopment.  
 The piglet has been used as a model for areas of nutritional research including LCPUFA 
metabolism, pre- and probiotic presence for intestinal health, and macro- and micronutrient 
deficiencies, all of which possess the potential to impact neurodevelopment and behavior 
(4,92,125,126). Considering the similarities between the pig and human, and its potential as a 
translational model for human nutrition, it is important to characterize the natural form of piglet 
nutrition, sow milk. Characterization of sow milk with respect to human BM and infant formula 
allows for alterations of human infant formula to fit the nutrient requirements of the pig, and 
subsequently permits for the assessment of dietary lipid metabolism on neurodevelopment. The 
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macronutrient composition of mature sow milk is higher when compared with human milk, with 
the exception of lactose (3,127). The energy content of sow milk is also higher, with sow milk 
providing 114 kcal/dL and human milk providing 68 kcal/dL. Lipid concentrations of sow milk 
are also higher at approximately 7.1 g/dL while human BM concentrations are approximately 3.5 
g/dL (123). Despite this difference in quantity, approximately 50% of total energy is provided 
from the lipid fraction of milk in both species, with a majority (~70%) of the lipid fraction being 
represented as TAG. Considering this similarity in the percentage of energy derived from fat, and 
heavy incorporation of TAG in the lipid fraction, the piglet model has been used to study the 
impact of artificial nutrition. The safety of DHA supplementation in infant formulas, and 
establishment of DHA as an essential nutrient in physiological and neurodevelopment, was 
originally conducted using a pig model (34,128). Thus, although the nutrient composition of sow 
milk is different than human BM, artificial infant formulas can be altered to meet the caloric and 
nutritive requirements of the pig to directly assess lipid metabolism.  
 The human infant GI tract is highly mature at birth, while the rodent model experiences 
majority of GI development postnatally. The rate of GI development that occurs in piglets is 
intermediate to that of the rodent and the human, and is therefore a more appropriate model for 
studying human GI development. For species that have relatively mature GI function at birth, the 
changes occurring in the gut epithelium in perinatal life are important, where development 
associated with weaning may be most important in rodent species (129). This allows for the pig 
to be a more appropriate model than rodents for nutritional studies.  
The Piglet as a Model for Nutritional Neuroscience 
The piglet has been used sparingly as a biomedical model to assess the impact of early-
life nutrition on cognitive development. Relative to the rodent model, piglets are highly 
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precocial, and can therefore be easily reared artificially, allowing for precise assessment of 
nutrient intake and body tissue accretion (123). The larger size of piglets allows for conventional 
means of assessing brain development including MRI, and easier sampling of tissues and blood 
to assess physiological development (124). Moreover, there are strong similarities between 
postnatal patterns of brain development between pigs and humans. The piglet and human infant 
have a comparable proportion of adult brain volume established at birth (20-25% of their 
ultimate weight). The rodent brain only achieves 12% of total brain weight at birth, while the 
non-human primate (rhesus monkey) is more mature with 75% brain development (130). In 
addition, structural and functional complexity of the cortical regions increases in perinatal life, 
and such comparisons from the gyrencephalic brain of the pig are more relevant to the human 
infant than with the lissencephalic rodent brain. Previous work has also correlated 
neurodevelopmental timelines in the human, in years of age, to the pig, in months of age, 
establishing the pig as an accelerated model for studying human brain development (131). 
Although similarities to the human infant in structural development are important, one of the 
primary strengths of the pig model is its ability to be trained in behavioral tasks. Examples of 
these tasks include the eight-arm radial maze and T-maze, which are designed to assess 
mechanisms of learning and memory (132). For example, the T-maze is designed to assess 
hippocampal-dependent spatial discrimination ability using visual cues and a food reward 
(126,133,134). Such behavioral tasks integrate functional learning and memory tasks with 
nutrition-induced variations in structural development of the infant brain.  
Summary and Thesis Objectives 
The neonatal brain undergoes a tremendous growth spurt during early post-natal life, 
characterized by a synchronized interplay of proliferative and regressive processes. 
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Neurodevelopment in the months following birth incorporate processes such as dendritic and 
axonal growth, synaptogenesis, differentiation and proliferation of glial cells, and myelination of 
axonal tracts (94). These neurodevelopmental milestones are particularly sensitive to nutritional 
insults (135), and can result in alterations from normative patterns of neuro and cognitive 
development (136). Docosahexaenoic acid is a nutrient of interest that has gained notoriety in 
recent years due to its abundance in neural membranes. Neural concentrations of this n-3 
LCPUFA is susceptible to dietary manipulation (15). A large scale incorporation of this n-3 FA 
in neural tissue is observed during early post-natal life, and a growing body of work connects 
DHA to structural development of the infant brain and cognitive abilities in later life (89). Many 
of these studies have suggested greater incorporation of DHA in breast-fed infants compared 
with their formula-fed counterparts (4,137). However, characterization of the dietary fat matrix 
in BM is incomplete, and further research is necessary to identify nutrient-based strategies to 
allow for optimal metabolism and neural incorporation of DHA. Therefore, the goal of this thesis 
is to identify the impact of pre-digestion of dietary TAG, as well as incorporation of emulsifiers 
such as lecithin and cholesterol, on DHA metabolism, as well as structural and functional 
outcomes related to intestinal and brain development. Our goal is to identify whether these 
strategies affect the intestinal epithelium that serves as a gateway for FA absorption, as well as 
identify patterns of DHA circulation and brain development as assessed by MRI techniques.  
The piglet has been increasingly used in characterizing the role of multiple nutrients 
including iron, cholesterol, and LCPUFA on brain development (126,138,139). The piglet is an 
excellent model to identify the impact of nutrient interventions, particularly that of lipids, on 
neurodevelopment due to similarities in the rate of brain development and similar patterns of 
lipid metabolism. In comparison with the rodent model, the piglet brain is more precocial, 
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allowing for nutrient intervention earlier in life, and offers a longer life-span to assess the impact 
of dietary intervention on brain development. The larger size of the piglet allows for the use of 
clinically-applicable tools such as MRI to assess brain development, and yields larger quantities 
of tissue for molecular analysis in comparison to the rodent model. Overall, the piglet is a highly 
translatable model that can provide high-quality and novel pre-clinical evidence regarding DHA 
metabolism and insight into how manipulation of the dietary fat matrix influences brain and 
intestinal development of the neonate.  
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Figure 2.1. The biosynthetic pathway involved in the synthesis of n-6 and n-3 long chain 
PUFA (9,11). 
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Figure 2.2. Pathways of fatty acid incorporation and metabolism in the brain (adapted from 
79).   
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Figure 2.4. Line spectra obtained from MRS indicating hippocampal 
neurochemical concentrations expressed in PPM.  
  
 
Figure 2.3. Illustration of T1-acquired image with labeled: 1) CSF, 
2) WM tracts, and 3) fat (adapted from 110). 
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Chapter 3 
IMPACT OF DIETARY LIPID MATRIX ON BRAIN MICROSTRUCTURE OF THE 
NEONATAL PIG 
Abstract 
The lipid matrix found in breast milk may benefit cognitive function and neural 
maturation in neonates. Using the piglet as a pediatric biomedical model, we assessed the impact 
of dietary fat composition on postnatal neurodevelopment. Over a 25-day study, piglets (n=9-
10/treatment, 1.5 ± 0.2 kg initial BW) were subjected to 1 of 3 experimental treatments: T1, 
artificially-reared (AR) control formula; T2, T1 with 45% of total dietary fat replaced by pre-
digested fat (PDF); T3, T2 + 10% lecithin + 0.4% cholesterol. Reference values obtained from 
sow-reared (SR) animals were not included in the statistical analysis when comparing treatments. 
Piglets were weighed daily, serum samples were collected at d 0, d14, and d25 of study, and 
fecal samples were collected, and pooled from d 13-27. At study conclusion, piglets were 
euthanized and tissues were collected for further analysis. Sow-reared piglets exhibited higher 
BW gain and heavier extracted whole brain weights compared with AR piglets. Analysis of fecal 
fat suggested greater (P < 0.05) excretion of dietary fat with addition of PDF along with lecithin 
and cholesterol. Serum lipid profiling at d 14 and d 25 revealed serum concentrations of 
triacylglycerides (TAG), lipoproteins and cholesterol to be higher in SR animals, with d25 serum 
cholesterol concentrations being higher (P < 0.05) in T3-fed piglets when compared with T1- 
and T2-fed piglets. Serum TAG concentrations at d14 and d25 remained higher (P = 0.176, P = 
0.164) in T3-fed piglets when compared with T1- and T2 fed piglets. Hippocampal tissue 
analysis revealed neutral lipid (NL) DHA concentrations were greater (P < 0.05) in T3-fed pigs 
compared with T1-fed and SR pigs. Hippocampal phospholipid (PL) DHA concentrations of T2- 
or T3-fed pigs were intermediate to T1-fed and SR piglets. Higher fecal fat excretion, partnered 
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with no differences in serum TAG concentrations compared with SR piglets, suggested higher 
bioavailability of the PDF, especially when supplemented with lecithin and cholesterol. 
Replacing part of formula TAG with PDF, and addition of lecithin and cholesterol, may elicit 
preferential accretion of brain DHA due to compositional manipulations of the dietary lipid 
matrix. 
Introduction  
Docosahexaenoic acid [DHA; 22:6 (n-3)] is increasingly promoted as a long-chain 
polyunsaturated fatty acid (LCPUFA) of critical importance for neural development of the 
neonate (1). It is the most prevalent n-3 fatty acid (FA) in the central nervous system, and serves 
as an integral structural component of neural membranes. Docosahexaenoic acid is primarily 
integrated into glycerophospholipids, including phosphatidylethanolamine (PE) and 
phosphatidylserine (PS), and its concentration in neural tissue increases substantially in the first 
year of life (2–4). Dietary supplementation with DHA has been associated with increased brain 
DHA accretion (5), increased visual acuity (6) and cognitive development (7) in animal models 
and in the human clinical setting. The predominant sources of infant nutrition in early life are 
breast milk (BM) and infant formula. An increasing number of studies (8–11) are focusing on the 
impact of these varying sources of nutrition on brain development, and the role of DHA in 
structural and cognitive development of breast-fed and formula-fed infants. 
An increasing body of clinical neuroimaging studies have revealed a favorable effect of 
BM on brain development (9,12), and as such, BM has been increasingly promoted as the 
optimal source of nutrition for the infant. The incorporation of preformed DHA in this medium 
has been suggested to influence modulations of early life neurodevelopment (12). Differences in 
DHA accretion between breast-fed and formula-fed infants have been noted as early as 6 months 
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of age. Consumption of infant formula without DHA supplementation resulted in average daily 
accretion of brain DHA at approximately half that of levels observed in breast-fed infants (13). 
Due to its neuro-augmenting nature, DHA was approved as an additive to infant formula in 2002 
at concentrations similar to those found in BM (14,15). Supplementation of pre-formed DHA is 
of critical importance to the developing infant, as the rate of endogenous DHA synthesis from α-
linolenic acid [ALA: 18:3 (n-3)] is quite slow, and is suggested to be insufficient to meet 
requirements of the developing infant (1,16–18). As such, supplementation of preformed DHA in 
infancy may be the best route to ensure optimal tissue accretion of this LCPUFA.  
Although the role of DHA in infant development has obtained notoriety in recent years, 
few studies have focused on identifying dietary strategies to improve tissue incorporation of 
DHA at levels similar to those found with BM. Presently, TAG, PL, or ethyl esters are the three 
primary sources of DHA in infant formula (19). The proportion of fat absorption has been 
reported to be higher with the incorporation of PUFA found in PL compared with TAG (20), but 
others have observed no differences in DHA absorption between subjects fed DHA as TAG 
versus PL (21). As for incorporation of DHA into neural tissue, incorporation into gray matter 
and synaptosome tissues appear to be higher when DHA is supplemented in TAG form, but 
DHA accretion in the same brain regions as a proportion of dosage was significantly higher from 
the PL fraction (provided as phosphatidylcholine) (19). Positional distribution of FA in the 
dietary TAG may affect pancreatic lipase mediated hydrolysis and subsequent absorption of 
saturated and polyunsaturated FA. Most saturated FA, such as palmitic acid, is esterified at the 
sn-2 position in BM. This positional specificity allows for a higher proportion of these FA to be 
absorbed when compared with cow milk or infant formula, which preferentially esterifies 
palmitic acid at sn-1 and sn-3 positions (22,23). Pancreatic lipase preferentially cleaves at the sn-
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1 and sn-3 positions of TAG, therefore we hypothesize that esterifying saturated FA to the sn-2 
position, and predigesting the sn-1 and sn-3 bound LCPUFA will allow for greater availability of 
DHA. 
The piglet has been successfully used human infant nutrition to characterize the role of 
multiple nutrients including iron (24), cholesterol (25), and PUFA (26) on neurodevelopment. 
Due to similarities in nutrient requirements, lipid metabolism, and patterns of brain development, 
the piglet serves as a powerful translational model for human infants (27–29). In addition, the 
precocial nature and expedited growth rate of the pig when compared with the human infant 
allows for nutrient intervention immediately following birth, and a rapid timeline on which to 
observe the influence of early-life nutrition on neurodevelopment.  
Using artificially-reared (AR) and sow-reared (SR) piglets as models for the formula-fed 
and breast-fed infants, respectively, the purpose of this study is to determine whether nutrient-
based strategies to manipulate the lipid matrix would allow for greater absorption, transport and 
incorporation of DHA into the brain. To assess differences between treatments, we outlined three 
primary objectives for this study: 1) identify whether pre-digestion of sn-1 and sn-3 bound 
LCPUFA, or the addition of lecithin and cholesterol, allow for improved absorption and tissue 
incorporation of DHA; 2) assess the impact of varying fat matrices on growth performance and 
integrity and maturity of the intestinal brush border; and 3) identify whether differences exist for 
any of the above-mentioned outcomes between AR and SR piglets.  
Materials and Methods  
All animal experimentation procedures were approved by the Institutional Animal Care 
and Use Committee at the University of Illinois, and followed guidelines from the National 
Institute of Health Guidelines for the Care and Use of Laboratory Animals. 
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Animals, Housing, and Feeding 
Naturally-farrowed, vaginally-derived piglets (n=10/treatment, 1.5 ± 0.2 kg initial BW; 
sourced from 10 sows, n=2/treatment from each sow) were obtained from the Imported Swine 
Research Laboratory herd located at the University of Illinois. Piglets were allowed access to 
colostrum for up to 48 h, at which point they were immediately allotted to one of 4 experimental 
treatments for the duration of a 25-d feeding study (conducted using 5 cohorts of piglets). Piglets 
were housed individually in stainless steel cages (101.6 cm L x 76.2 cm W x 81.28 cm H), and 
were provided with a towel and toy (Bio-Serv, Flemington, NJ) for comfort and environmental 
enrichment. Cages were fitted with vinyl-coated expanded-metal flooring (Tenderfoot/NSTM), 
which was designed for neonatal piglets, and were also outfitted with a heat lamp and electric 
heat mat (K&H Manufacturing, Colorado Springs, CO) to maintain home cage temperatures 
between 23-31°C. A 12-h light/dark cycle was maintained with minimal light provided during 
dark cycles for the duration of the study.  
Artificially-reared animals were fed 1 of 3 isocaloric dietary treatments as follows: T1, 
AR control formula; T2, T1 with 45% total dietary fat replaced by pre-digested fat (PDF); T3, T2 
+ 10% lecithin + 0.4% cholesterol. Sow reared animals (T4) remained with their respective 
mother and litter mates for the duration for the study (Table 3.1).  
 Artificially-reared piglets were fed using an automated feeding system that dispensed a 
pre-determined volume of formula over a period of 13 ± 2 h based on daily BW of piglets. The 
diets were replaced twice daily and were dispensed from 6 identical reservoirs that were cleaned 
and sterilized daily. Piglets were fed 285 ml/kg BW, 300 ml/kg BW, and 325 ml/kg BW from 0-
7, 8-16, and 18-25 d on study, respectively.  
 Per agricultural protocols, all piglets were identified at birth using ear notches, and 
further, needle teeth were removed to prevent harm to littermates and the sow. Moreover, piglets 
 53 
 
received a supplemental iron injection at 1 d of age, but did not undergo other agricultural 
processing (i.e., tail docking and castrations did not occur). Approximately 5 ml of clostridium 
perfringens antitoxin C + D (Colorado Serum Company, Denver, CO) was administered 
subcutaneously as a prophylactic agent at d 2 of age. If piglets developed diarrhea, supplemental 
water and electrolytes (Pedialyte, Abbott Laboratories, Abbott Park, IL) were provided. 
Sulfamethoxazole and trimethroprim oral suspension (50 and 8 mg/mL, respectively, Hi-Tech 
Pharmacal, Amityville, NY) were given if symptoms were not alleviated after 48 h of exhibiting 
initial symptoms.  
Individual piglet body weights were recorded daily to assess growth performance, and 
blood samples were collected on study d 0, 14, and 25. Blood was collected in to serum tubes 
(BD Franklin Lakes, NJ, USA), gently inverted and centrifuged at 1300 x g for 15 minutes at 
20°C. Serum samples were obtained and processed at all-time points for analysis of serum lipid 
levels. Serum was obtained and stored at -80°C until further processing. Serum samples were 
analyzed for HDL, LDL, TAG and cholesterol using established methods (Lipoprotein 
Composition Laboratory, University of Tennessee, Knoxville, TN). Red blood cells (RBC) were 
collected on study d 25, and all samples were stored at -80°C pending subsequent analyses.  
Fecal samples were collected between study d 13-17, and samples were stored at -80°C. 
 At study conclusion (i.e., d 27 of age), piglets were euthanized for tissue and blood 
collection. All animals were euthanized in the fed state with respective treatments being provided 
until an hour before administering anesthesia. Piglets were anesthetized using an intramuscular 
injection of telazol:ketamine:xylazine administered at 0.022 mL/kg BW. Pain reflex and eye 
blink response were tested to ensure deep anesthesia before euthanizing animals with an 
intracardiac injection of 390 mg/mL sodium pentobarbital solution at 1 mL/5 kg BW. Blood was 
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collected immediately after euthanasia and processed for serum and RBC fractionation. Whole 
brains were extracted and select brain regions, including the left and right hippocampi, were 
dissected, snap frozen in liquid nitrogen, and stored at -80°C pending analyses.  
The small intestine, spanning from the pyloric sphincter to the ileocecal junction, was 
dissected and weighed. The intestine was separated from mesentery, and segmented into 10, 75 
and 15% of the total length to identify duodenal, jejunal, and ileal sections, respectively (30). 
The jejunum was folded in half to identify proximal and distal sections of the jejunum. A 25 cm 
segment was collected from the middle of the proximal part of the jejunum. Approximately 20-
cm segment was resected and the luminal surface was exposed for collection of mucosa. The 
adjacent 5-cm segment was opened longitudinally and stored in 10% neutral buffer formalin for 
histomorphological analysis of brush border maturity. Samples were submitted to the University 
of Illinois Veterinary Diagnostic Laboratory where samples were embedded in paraffin, 
sectioned, and stained with hematoxylin and eosin. Samples were visualized using the 
Nanozoomer Digital Pathology system at the University of Illinois Institute for Genomic 
Biology. Villi surface area was calculated from the apical width (d), basal width (c), and villi 
length (a) using the following formula (c + d)/2*a (31).  
Quantification of docosahexaenoic acid in red blood cells and brain 
Lipids were extracted from RBC and hippocampal samples using a methanol and 
chloroform procedure (32,33). Briefly, RBC were added drop-wise into a known amount of cold 
methanol and agitated in a sonicating water bath. For hippocampal tissue, approximately 0.15 g 
of tissue was homogenized in cold methanol using a bead homogenizer. In total, a 2:1 ratio of 
chloroform/methanol was then added to the homogenized solvent, with further agitation to 
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achieve final ratio of 50:1 solvent to sample. The solution was then filtered through filter paper 
(Whatman® 541, Sigma Aldrich, St. Louis, MO) to remove precipitated proteins, and the 
resulting supernatant was dried under a stream of argon. The remaining lipid residue was 
resuspended in 2 ml of chloroform, and separated into PL and NL fractions using HyperSepTM 
Silica SPE Cartridges (Thermo Scientific, Waltham, MA) conditioned with 10 ml chloroform. 
The NL fraction of fatty acids was eluted with 20 ml chloroform, and the PL fraction was eluted 
with 20 ml methanol. Solutions isolated using these procedures were separately dried under a 
stream of argon, and all samples were stored at 4°C until processed for methylation (34).  
The lipid residue obtained from the extraction process was re-suspended in 1.8 ml 
hexane, and 0.2 ml of an internal standard (pentacosanoic acid; 25:0, 20.06 µg/ml). The solution 
was hydrolyzed and methylated using 3 ml of methanolic-HCl and incubated for 1 hour at 100°C, 
before samples were resuspended in 5 ml of potassium carbonate and 2 ml hexane. Following 
centrifugation, the resulting upper fraction containing long chain fatty acids was obtained, 
protected from light, and dried under a stream of argon. The methylated fatty acid residue was 
transferred to amber vials and fatty acid methyl esters were analyzed by gas chromatography 
according to established procedures (35). Fatty acids were identified by comparing retention 
times to known standard mixtures. 
Analysis of fecal fat  
Fecal samples were collected into sterile sampling bags (Whirl-Pak, Pioneer Container 
Corp, Cedarburg, WI) and stored at -20°C until further processing. Fecal samples were dried at 
57°C in a forced-air oven and ground (Model 4 Wiley Mill; Thomas Scientific, Swedesboro, NJ) 
using a 2 mm screen. Samples were subsequently analyzed for dry matter (DM), organic matter 
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(OM), and acid hydrolyzed fat (36,37). To calculate proportion of DM and OM in fecal samples, 
a minimum of 200 mg sample was dried at 105°C overnight, and subsequently ashed at 600°C. 
To quantify crude fat content, acid hydrolysis of fecal matter was conducted (36). In brief, a 500 
mg sample was saturated with 95% ethanol and hydrolyzed with 10 ml of 25% HCl solution and 
heated in a water bath at 75.5°C. A regimen of 25 ml ethyl ether and 25 ml petroleum ether, 
followed by 15 ml ethyl ether and 20 ml petroleum ether, was used to extract crude fat from the 
fecal samples. The top layer containing ether-bound fat was collected and ether was evaporated 
in a steam bath. Crude fat weights were obtained prior to drying samples in a 135°C oven. 
Percent fat was calculated using the following equation:  
Fat (%) =
 Fat weight (g) 
Sample weight on DM basis (g)
∗ 100 
 
All procedures were completed in duplicate, and the assay was repeated if calculated error 
exceeded 5%. 
Statistical Analysis 
Data were subjected to an analysis of variance (ANOVA) using the MIXED procedure of 
SAS, version 9.4 (SAS Institute Inc., Cary, NC). Replicate of pigs was included as a random 
variable, and the threshold of significance was set at P < 0.05. Data collected from a single time-
point were analyzed using a one-way ANOVA, while any measures acquired from the same 
animal over multiple time-points were analyzed using a repeated-measures ANOVA.  Values 
obtained from SR animals were designated as reference values, and thus were not included in the 
statistical analysis when comparing treatments.  
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Results 
Growth performance and organ weights 
Growth performance of SR piglets was greater than all other treatments (Table 3.2,), with 
no significant differences between AR groups. However, no differences (P > 0.05) were 
observed in average daily BW gain during the last week of life, indicating a similar growth 
trajectory for the SR and AR piglets during this period.  
Compared with AR piglets, SR piglets had numerically heavier absolute whole-brain 
weights, and lighter whole-brain weights expressed relative to BW (Table 3.3). No differences 
were detected within AR treatments for absolute or relative whole-brain weights. Sow-reared 
piglets exhibited numerically smaller absolute and relative small intestine weight and length 
when compared with AR piglets. No differences were detected within AR treatments in small 
intestine and length measurements. Intestinal weight, as a percentage of body weight, was greater 
(P < 0.05) in AR female piglets, but no interactive effects of treatment and sex were observed in 
these measurements. Whole-liver weights were not different between treatments, but liver 
weights as a percentage of body weight were numerically lighter in SR piglets. 
Serum lipids 
No differences in any serum lipids were observed at the beginning of the study (Table 
3.4). At 16 and 27 d of age, serum TAG, HDL, LDL, and cholesterol were all numerically higher 
in SR piglets compared with all AR treatments. Serum TAG levels at d16 were trending (P = 
0.176) to be higher in T2 and T3 animals when compared with T1 animals. Similarly, serum 
LDL levels at were trending (P = 0.069) to be highest in T2 animals with in the AR experimental 
groups. Treatment effects were also noted within AR treatments at 27 d of age for serum TAG, 
HDL and cholesterol, with serum TAG levels trending (P = 0.164) to be highest in T3 animals 
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when compared with T2 and T1- fed groups. Serum HDL concentrations were higher (P < 0.05) 
in T2 and T3 when compared with T1-fed animals. Circulating serum cholesterol levels were 
higher (P < 0.05) in T3-fed animals when compared with T1-fed animals. No differences in 
serum cholesterol were observed in piglets fed T1 vs. T2, and T2 vs. T3. Finally, female pigs had 
higher (P < 0.05) HDL concentrations pigs at 27 d of age. This serum lipid measure represents 
the only outcome in the study where a significant sex effect was observed.  
Fatty acid analysis of red blood cells (RBC) and brain 
Hippocampal DHA concentrations in the NL fraction were higher (P < 0.05) in T3-fed 
AR piglets when compared with T1, T2 or SR reference animals (Figure 3.1, Table 3.5). Within 
AR groups, a graded increase (P < 0.05) in hippocampal neutral lipid DHA concentration was 
observed in piglets fed T2 vs. T1, and T3 vs. T2, with DHA concentrations of SR animals falling 
between those of T1 and T2. Phospholipid DHA concentrations of RBC were different (P < 
0.05) between treatments, with highest concentrations of DHA being present in T2-fed animals. 
No differences were observed between T1 and T3, or T1 and T2-fed animals. No other 
differences in hippocampal or RBC DHA concentrations were observed. A numerical increase (P 
= 0.240) in hippocampal DHA concentration was observed in the PL fraction of pigs fed 
treatments T2 or T3, with highest DHA concentrations observed in T3-fed pigs when compared 
with either T1 or SR treatments. However, no differences in DHA concentrations due to 
treatment were observed in hippocampal PL or RBC NL fractions.  
Whole-brain DHA was calculated based on hippocampal DHA concentration and 
absolute whole-brain weights at study conclusion. Although no significant differences in whole-
brain DHA accretion were present, a numerical increase (P = 0.084) was observed in the NL 
fraction of pigs fed treatments T3 when compared with T1 and T3. In accordance with 
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hippocampal PL and NL observations, the highest calculated quantity of whole-brain DHA in PL 
and NL fraction was present in piglets fed T3.   
Fecal fat  
Percentage of fecal OM was higher (P < 0.05) in piglets receiving T1 compared with T3, 
and pigs fed T2 exhibited an intermediate response (Table 3.6). Percentage of fecal fat, 
presented on an OM basis, was higher (P < 0.05) in T2 and T3 groups compared with T1. No 
differences due to treatment were observed in fecal DM, but a numerical increase (P = 0.0582) 
was observed in percentage of fecal fat on a DM basis for T2 and T3 compared with T1.  
Histological analysis of jejunal tissue samples 
Brush border maturity in the jejunum was assessed via outcomes including villi height, 
villi surface area and crypt depth. Histological analysis of the brush border revealed all variables 
to be shorter in SR animals when compared with AR treatment groups, with no differences 
observed between AR treatments (Figure 3.2). No significant differences in villi morphology, 
nor villi surface area, were observed between any treatments.  
Discussion 
Using the piglet as a biomedical model, this study sought to investigate the impact of 
manipulating the dietary lipid matrix found in infant formula on the absorption and integration of 
DHA into neural tissue. Artificially-reared piglets were raised individually and fed 1 of 3 
isocaloric dietary treatments, while SR reference animals remained with the dam and littermates 
for the duration for the study. Our findings indicated improved growth performance and overall 
elevated serum lipid concentrations in SR piglets compared with AR piglets. Analysis of 
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hippocampal tissue also indicated that transport of DHA to the brain via the neutral lipid fraction 
may be a primary route of DHA transport.  
Growth performance  
Although AR animals never reached the growth trajectory observed in SR animals, 
average BW gain during the last week on study indicated a similar growth rate between the 2 
rearing conditions (data not shown). Established patterns of growth in human infants indicate no 
consistent differences in weight gain in the first 1-2 months of life between breast-fed and 
formula-fed infants, but the rate of BW gain is reported to be higher in formula-fed infants from 
2 months to 1 year of age (34, 35). Our AR animals did not reach the growth trajectory observed 
in SR animals, and therefore did not concur with aforementioned patterns of human 
development, the lack of differences in the rate of BW gain in the third week of life suggest that 
similar patterns of growth may be present between treatments if animals were brought to 2 or 3 
months of life. To further elucidate drivers of BW gain and brain development, we chose to 
focus our efforts on characterizing the impact of varying lipid profiles of maternal milk and 
infant formula on overall metabolism.  
Serum lipids  
As expected, characterization of serum lipids revealed higher HDL, LDL and cholesterol 
concentrations in SR animals compared with their AR counterparts. Of particular interest were 
the elevated levels of serum cholesterol at d 16 and d 27 of age in SR animals when compared 
with AR treatments. Similar to our observations, breast-fed infants exhibit higher serum 
cholesterol levels when compared with formula-fed infants, which is likely due to the elevated 
cholesterol content of human milk (90-150 mg/L) as compared with most cow milk-based 
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formulas (10-40 mg/L) (40). Although a 2-4-fold increase of serum cholesterol during breast-
feeding coincides with an period of substantial cholesterol accretion and white matter maturation 
within the CNS (41), most current evidence suggests a primary dependence on endogenously 
synthesized cholesterol to meet neurodevelopmental requirements. Approximately 95% of 
cholesterol required for processes such as myelination is synthesized within the glial cells of the 
central nervous system (41,42). However, 3H labeling of unbound cholesterol has revealed low 
levels of its transport in the capillary endothelium of rodents (5), and minimal incorporation of 
hexadeuterium-labeled cholesterol from circulation into the cerebrum and cerebellum in the adult 
guinea pig (43). Therefore, elevated levels of circulating cholesterol as seen in T3 can result in 
an increase in cerebral cholesterol concentrations.  It is plausible that a small, but critical, amount 
of circulating cholesterol may be transported through tight junctions of the blood brain barrier 
(BBB). The expression of bidirectional transporters such as LDL receptor (LDLR), scavenger 
receptor class B type 1 (SRB1), and unesterified cholesterol transporters such as ABCA1 (41) 
could provide the missing link between high serum cholesterol of the breast-fed infant, and high 
level of brain cholesterol accretion that mediates white matter maturation.  
As a separate component of this study, magnetic resonance imaging (MRI) techniques 
were used to assess white matter maturation in the developing piglet brain. Overall, our MRI 
results suggested greater myelination of white matter tracts in the SR animal when compared 
with AR piglets. Cholesterol is an essential component of myelin, therefore we were interested in 
characterizing any existing correlations between supplementation of dietary cholesterol and MRI 
outcomes. As previously suggested, there is minimal, yet impactful incorporation of circulating 
cholesterol in to the cerebrum. As such, The higher levels of myelination observed in the SR 
animal as compared with AR animals can be due to the elevated levels of circulating cholesterol. 
 62 
 
In support of this hypothesis, we observed a 20% increase in serum cholesterol in T3-fed pigs 
when compared with T1-fed pigs at 27 d of age. Although we did not observe outcomes 
indicating greater myelination on a whole-brain level with the addition of lecithin and cholesterol 
to the PDF system, region specific assessment of internal capsule (IC) myelination indicated 
similar trajectory for white matter development between T3 and SR reference animals. The IC is 
a white matter-rich region that experiences early maturation relative to the cortices (44). 
Considering the lack of differences in the IC, partnered with the highest level of serum 
cholesterol observed in T3-fed piglets when compared with all other AR groups, this suggests an 
impact of supplementation of dietary cholesterol on brain cholesterol accretion. Although these 
interpretations are purely speculative, uptake of dietary cholesterol at rates too low to be detected 
by current methods may be present. Such incorporation of dietary cholesterol could provide 
means for supplementing the in situ generation of brain cholesterol. However, further 
investigation, including the expression of cholesterol transporter proteins in the BBB and 
radiolabeling of dietary cholesterol, is warranted to elucidate the extent to which dietary 
cholesterol is incorporated into the brain during perinatal neurodevelopment.   
Fatty acid analysis of hippocampal tissue and red blood cells  
Data from our study suggest that hippocampal accretion of DHA is primarily occurring 
through the NL fraction. In addition, these results suggest greater incorporation of DHA due to 
the novel lipid strategies that were employed. Treatments 1 and 2 incorporated 140 mg/kg of 
DHA, while T3 included DHA at 150 mg/kg. The 7% increase in DHA incorporation in T3-fed 
pigs allowed for a 17% increase in hippocampal NL DHA when compared with T2-fed pigs, and 
a 30% increase when compared with T1-fed pigs. This increase in hippocampal DHA suggests 
that the PDF + lecithin + cholesterol fat system optimized incorporation of DHA into the NL 
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fraction of hippocampal tissue. Although not statistically significant, hippocampal PL DHA 
concentration increased by 1.2-fold with the addition of PDF, and 2.2-fold with the PDF + 
lecithin + cholesterol fat system compared with the control formula (T1). 
 Lysophosphatidylcholine (lysoPC, i.e., lysolecithin) has been suggested as a preferred 
carrier of DHA to the brain and erythrocytes (45). It is generally accepted that the transport of 
DHA into the brain is bound to albumin (46), but serum albumin also binds lysoPC. Previous 
studies have revealed that 14C-labeled lysoPC-bound DHA (47), ARA, linoleic and oleic acids 
(48) are taken up by the rat brain at 5-to-10-fold greater efficiency when compared with the non-
esterified forms. Thus, greater incorporation of PL DHA in the hippocampus may be due to the 
preferential transport of albumin-associated, lysoPC-bound DHA across the BBB. Our study did 
not support the preferential incorporation of DHA via lysoPC into the erythrocyte, as the 
concentration of RBC PL DHA decreased in pigs fed the PDF + lecithin + cholesterol fat system 
when compared with the PDF fat system alone. However, the dietary lipid profiles of our 
artificial formulas were successful in increasing the concentration of PL bound DHA in RBC as 
a percentage of DHA present, when compared with SR piglets.  
Martin et al. suggests that DHA is first incorporated into NL fraction upon uptake within 
cerebral tissues, and only then fractioned into glycerophospholipids such as PE and PC (49). 
Such sequential release of FA from NL to PL allow for storage of DHA in NL such as TAG, and 
provides a possible explanation for the increase in the NL fraction of hippocampal DHA with the 
PDF + lecithin + cholesterol fat system. Although not significant, we observed a similar graded 
increase in the PL fraction when comparing T2 vs. T1 and T3 vs. T2. If our data follows the 
hypothesis put forward by Martin et al. (47), it is plausible that lecithin-bound DHA exhibits 
preferential transport across the BBB as compared with the non-esterified DHA. Such PL-
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mediated transport may help to explain the reduction of PL-bound RBC DHA concentrations in 
T3 when compared with T2.  
Although the relationship between RBC and brain DHA is not fully elucidated, our data 
suggest that pre-digestion of dietary lipids allow for greater absorption of DHA across the 
intestinal endothelium. However, it could be the addition of lecithin that allows for preferential 
incorporation of DHA into nervous tissue subsequent to transport across the BBB. Perfusion 
studies have shown that addition of bovine serum albumin to unesterified DHA decreased the 
brain transport coefficient (5) of PUFA, further supporting the notion that albumin as a 
preferential transporter of DHA in the blood. Albumin-bound DHA should be further 
investigated to verify that the combined action of PDF and lecithin is in fact responsible for 
greater levels of DHA observed in erythrocytes and brain tissue. In addition, Ouellet et al., and 
others (46) suggest a preferential and passive incorporation of unesterified PUFA across the 
BBB, with lipolysis occurring at the neural endothelium. As such, quantifying albumin-bound 
DHA as well as lipase activity at the BBB may provide insights into the combined activity of 
PDF and lecithin on the transport of DHA into neural tissue.   
Fecal fat 
Percentage of fecal fat excretion was highest in piglets provided with the PDF and PDF + 
lecithin + cholesterol fat systems. These data are surprising because these diets were formulated 
to reflect fat content of sow milk with reported values of 5.5% w/w (55 g/L) (50) to 6.2% w/w 
(51) under standard dietary conditions. Incorporation of mostly unsaturated and monounsaturated 
fat sources at ~10% yielded fecal fat excretion ranging from approximately 14-22% (52). 
Considering that artificial formulas used in this study incorporated between 66-73 g/L of fat, the 
fecal fat excretion ranging from 35 to 50% is over 2-fold higher than expected. We anticipated 
 65 
 
the PDF fat system would reduce fecal fat excretion as supplementation of PUFA have 
previously been demonstrated to induce a reduction in total fatty acid excretion on a wt. % basis 
(53). Addition of egg yolk PL has also been demonstrated to have favorable effects of fat 
emulsification, and thereby reduce fecal fat excretion (54), but again, we did not observe a 
reduction in fat excretion in T3-fed pigs when compared with T1- or T2-fed animals. Despite an 
increase in fecal fat excretion, serum TAG concentrations at both sampling points (d 14 and d 25 
of study) were most similar between T3 and SR animals. These results suggest that although a 
lower proportion of T3 dietary lipids were absorbed, inclusion of lecithin as an emulsifier may 
have mediated more efficient incorporation of dietary TAG into circulation.   
Histological Analysis of proximal jejunum 
Postnatal development of the intestinal epithelium is not well characterized in humans, 
but animal studies have indicated a hypertrophic effect of formula-feeding on small intestine 
morphology. Previous studies on neonatal piglets and humans, respectively, have revealed 
similar patterns as those observed in our results, with an increased weight of the intestine (55), 
and up to 30% increase in crypt depth (56). In our study, histological analysis of the proximal 
jejunum revealed a reduction in crypt depth, and a trend indicating lower villi surface area in SR 
than in any AR treatment groups. Previous studies in rodents have suggested a reductive effect of 
n-3 PUFA on epithelial cell proliferation partnered with increased apoptotic levels (57). 
Moreover, modulation of  mucosal architecture, characterized by shorter villi and crypt depth, 
were also reported in piglets supplemented with linseed oil high in n-3 PUFA (58). Our results 
are in consensus with these observations, as our data indicate shorter crypt depth and an 
incremental, numerical decrease in villi length in T2- and T3-fed animals compared with control 
pigs (T1). These results suggest that greater availability of PUFA in the diet, due to pre-digestion 
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of fatty acids, as well as the addition of lecithin and cholesterol, elicits intestinal morphology 
most closely similar to that of maternally-reared subjects.  
Conclusion 
Our findings indicate that the primary route of DHA accretion in hippocampal tissue 
occurs through the NL fraction. Incremental addition of lecithin and cholesterol with the PDF 
system appears to positively modulate DHA incorporation within this predominantly white 
matter-rich brain region. Although not statistically significant, we see similar trends in PL bound 
DHA accretion, indicating a need for further research in this area. Overall, further quantification 
of DHA in grey matter-rich regions, such as cerebral cortex or cerebellum, is required before 
extrapolating the impact of the applied dietary fat systems on whole brain DHA accretion. 
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Tables 
 
Table 3.1 Nutrient composition of experimental artificial formulas and reference sow milk values 
 
  Experimental Treatment
1  
 per kg of DM per L of formula 
per L of sow 
milk 
 T1 T2 T3 T1 T2 T3 Reference
2 
Proximate analysis        
Energy, kcal 1179 1197 1154 1129 1143 1102 1000  
Density, g 5.11 5.03 5.07 - - - - 
Total solids, % - - - 20.45 20.83 20.67 - 
Protein, g 249.6 251.2 256.2 53.3 54.8 55.5 55 
Crude fat, g 329.6 337.5 306.7 70.4 73.6 66.4 55 
Ash, g 47.92 55.21 56.12 10.23 12.04 12.15 - 
Lipid profile        
Linoleic acid, g 72.03 58.76 65.55 15.38 12.82 14.20 0.715  
α-Linolenic acid, g 7.78 4.61 6.29 1.66 1.01 1.36 0.033  
Arachidonic acid, g 1.467 1.488 1.548 0.313 0.325 0.335 0.061  
Docosahexaenoic acid, g 0.685 0.672 0.726 0.146 0.147 0.157 0.006  
Cholesterol, mg - - - - - 280 - 
Lecithin, g - - - - - 7.3 - 
Minerals         
Calcium, g 7.29 9.79 10.06 1.56 2.14 2.18 - 
Chloride, g 5037 4945 4935 1076 1078 1069 - 
Copper, mg 5.38 5.42 5.32 1.15 1.18 1.15 - 
Iodide, µg 1614 2208 2177 344.6 481.6 471.5 - 
Iodine, µg 2748 2252 2240 586.9 491.0 485.1 - 
Iron, mg 109.05 115.70 111.76 23.29 25.23 24.20 - 
Magnesium, mg 899.76 868.94 899.85 192.15 189.51 194.87 - 
Manganese, mg 0.83 0.89 0.98 0.18 0.19 0.21 - 
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Table 3.1 Nutrient composition of experimental artificial formulas and reference sow milk values continued 
Molybdenum, µg 295.8 274.6 306.7 63.2 59.9 66.4 - 
Phosphorus, g 4.45 4.48 4.80 0.95 0.98 1.04 - 
Potassium, g 10.32 10.95 10.93 2.20 2.39 2.37 - 
Selenium, µg 333.5 347.6 336.7 71.2 75.8 72.9 - 
Sodium, g 3.89 3.78 3.88 0.831 0.824 0.841 - 
Zinc, mg 50.86 54.25 52.73 10.86 11.83 11.42 - 
Vitamins        
A, IU 32910 27796 35704 7028 6062 7732 - 
D3, IU 6210.3 5760.9 6628.0 1326.3 1256.4 1435.4 - 
E, mg 113.45 100.82 112.72 32.95 29.90 33.20 - 
K, µg 1535.45 1137.78 1369.13 327.91 248.14 296.50 - 
B1,Thiamine, mg 11.59 11.38 11.51 2.47 2.48 2.49 - 
B2, Riboflavin, mg 13.64 13.35 13.26 2.91 2.91 2.87 - 
B3, Niacinamide, mg 72.86 72.97 71.60 15.56 15.91 15.51 - 
B5, Pantothenic Acid, mg 49.88 51.37 48.38 10.65 11.20 10.48 - 
B6, Pyridoxine, mg 3.69 3.73 3.70 0.79 0.81 0.80 - 
B7, Biotin, µg 567.24 528.08 532.17 121.14 115.17 115.25 - 
B9, Folic Acid, µg 1633.3 1517.0 1412.7 348.8 330.9 305.9 - 
B12, µg 60.64 53.29 58.54 12.95 11.62 12.68 - 
C, mg 1100.24 921.75 1146.59 234.97 201.02 248.30 - 
Choline, mg 1545.23 1445.03 2186.74 330.00 315.15 473.56 - 
Lutein, µg 4.16 4.37 5.22 890.00 950.00 1130.00 - 
1Experimental treatments include T1, artificially-reared control; T2, PDF; T3, PDF + lecithin + cholesterol.  
2 Reference values obtained from Foote et al., 1990. 
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Table 3.2 Growth performance of artificially-reared (AR) and sow-reared piglets (SR)1 
 Experimental Treatment2 P-value 
Variable3 T1 T2 T3 SR Reference Treatment Sex 
n  9 10 10 10   
Initial BW (d 2), kg 1.51 ± 0.10 1.49 ± 0.09 1.51 ± 0.09 1.59 ± 0.10 0.965 0.159 
Final BW (d 27), kg 5.12 ± 0.32 5.08 ± 0.31 5.46 ± 0.31 8.47 ± 0.47 0.582 0.277 
Overall BW gain, kg 3.60 ± 0.28 3.58 ± 0.27 3.96 ± 0.27 6.91 ± 0.43 0.482 0.340 
 Week 1 36.80 ± 9.26 50.46 ± 8.83 47.74 ± 8.83 199.10 ± 13.76 0.542 0.818 
 Week 2 123.80 ± 14.33 116.60 ± 13.91 138.90 ± 13.91 290.50 ± 18.07 0.317 0.862 
 Week 3 227.90 ± 15.84 224.90 ± 15.11 246.60 ± 15.11 235.20 ± 18.74 0.558 0.497 
 Overall 144.05 ± 11.05 143.39 ± 10.71 158.26 ± 10.69 276.88 ± 16.00 0.482 0.340 
a-bMeans within a row lacking a common superscript letter differ (P < 0.05). 
1Values are presented as means ± SEM.  
2Experimental treatments include AR (T1-T3) and SR groups. T1, AR control; T2, PDF; T3, PDF + lecithin + cholesterol. Reference values obtained from SR 
piglets were not included in the statistical analysis when comparing treatments. 
3Abbreviations: BW, body weight. 
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Table 3.3 Organ growth of artificially-reared (AR) and sow-reared (SR) piglets1 
 Experimental Treatment2 P-value 
Response variable3 T1 T2 T3 SR Reference Treatment Sex 
n 9 10 10 10   
Absolute brain weight, g 41.79 ± 1.345 40.38 ± 1.293 40.76 ± 1.293 46.17 ± 1.328 0.680 0.92
5 Relative brain weight, %4 0.84 ± 0.055 0.82 ± 0.052 0.75 ± 0.052 0.59 ± 0.056 0.448 0.11
9 GIT weight, g 342.64 ± 31.351 343.76 ± 30.690 384.74 ± 30.690 284.20 ± 31.588 0.226 0.07
7 GIT weight, %4,5 6.75 ± 0.454 6.68 ± 0.450 7.01 ± 0.450 3.41 ± 0.376 0.376 0.05
7 GIT length, m 7.67 ± 0.575 7.88 ± 0.567 7.48 ± 0.567 6.59 ± 0.527 0.621 0.90
3 GIT length, %4 0.16 ± 0.009 0.16 ± 0.009 0.14 ± 0.009 0.08 ± 0.009 0.178 0.18
2 n 7 8 
8 
8 8   
Liver weight, g 226.44 ± 26.094 224.63 ± 24.877 254.80 ± 25.047 249.99 ± 23.126 0.491 0.54
4 Liver weight, %4 4.49 ± 0.217 4.37 ± 0.208 4.61 ± 0.209 2.68 ± 0.187 0.569 0.94
5 1Values are presented as means ± SEM with threshold for significance set at P < 0.05. 
2Experimental treatments include AR (T1-T3) groups. T1, AR control; T2, PDF; T3, PDF + lecithin + cholesterol. Reference values obtained from SR piglets 
were not included in the statistical analysis when comparing treatments.  
3Abbreviations: GIT, gastrointestinal tract. 
4Expressed relative to body weight at d27 of age. 
5Relative GIT weight was greater (P < 0.05) in female piglets when compared with male pigs. 
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Table 3.4 Serum lipid concentrations (mg/dL) in artificially-reared (AR) and sow-reared (SR) piglets 1 
 Experimental Treatment2 P-value 
Response Variable3 T1 T2 T3 SR Reference Treatment Sex 
Day 04           
 n 9 10 10 10   
 TAG, mg/dl 113.6 ± 30.35 92.7 ± 29.48 130.2 ± 29.48 134.3 ± 31.12 0.481 0.839 
 HDL, mg/dl 26.4 ± 3.78 23.4 ± 3.70 24.4 ± 3.70 29.4 ± 4.33 0.646 0.990 
 LDL, mg/dl 36.8 ± 5.78 35.1 ± 5.65 30.3 ± 5.65 40.9 ± 7.00 0.424 0.557 
 Cholesterol, mg/dl 85.6 ± 13.16 76.9 ± 12.99 80.9 ± 12.99 97.2 ± 15.40 0.635 0.678 
Day 144           
 n  9 10 10 10   
 TAG, mg/dl 64.8 ± 11.88 91.1 ± 11.33 93.8 ± 11.33 119.4 ± 10.72 0.176 0.572 
 HDL, mg/dl 45.6 ± 4.23 44.3 ± 4.06 45.2 ± 4.06 75.7 ± 3.80 0.968 0.809 
 LDL, mg/dl 17.2 ± 2.37 24.4 ± 2.28 20.7 ± 2.28 86.9 ± 6.70 0.069 0.549 
 Cholesterol, mg/dl 75.6 ± 5.73 87.1 ± 5.46 84.5 ± 5.46 186.5 ± 8.30 0.339 0.723 
Day 254           
 n 8 10 8 9   
 TAG, mg/dl 44.9 ± 12.43 40.0 ± 12.10 55.7 ± 12.43 71.4 ± 12.03 0.164 0.510 
 HDL, mg/dl5 30.8 ± 2.83b 38.7 ± 2.65a 41.2 ± 2.83a 69.4 ± 3.51 0.005 0.057 
 LDL, mg/dl 29.8 ± 3.46 32.5 ± 3.18 34.3 ± 3.46 96.3 ± 5.50 0.548 0.867 
 Cholesterol, mg/dl 69.0 ± 6.91b 76.0 ± 6.60ab 86.2 ± 6.91a 180.3 ± 7.02 0.031 0.108 
a-b Means within a row lacking a common superscript letter differ (P < 0.05). 
1Values are presented as means ± SEM. 
2Experimental treatments include AR (T1-T3) groups. T1, AR control; T2, PDF; T3, PDF + lecithin + cholesterol. Reference values obtained from SR 
piglets were not included in the statistical analysis when comparing treatments.  
3Abbreviations: TAG, triacylglycerol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; CHOL, cholesterol. 
4Serum samples were collected on d0, d14 and d25 of study which coincides with d1, d16, and d27 of life.  
5D27 serum HDL concentrations (mg/dL) were higher in female piglets when compared with male piglets.  
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Table 3.5 Hippocampi and red blood cell (RBC) concentrations of DHA in artificially-reared (AR) and sow-reared (SR) piglets1 
 Experimental Treatment
2 P-value 
Sample Type3 T1 T2 T3 SR Reference Treatment Sex 
n 8 10 10 10   
RBC PL 9.4 ± 2.71ab 13.0 ± 2.73a 7.3 ± 2.78b 4.2 ± 2.81 0.052 0.902 
RBC NL 4.8 ± 1.32 5.1 ± 1.12 4.1 ± 1.41 4.3 ± 0.88 0.849 0.727 
HP PL 125.5 ± 83.05 138.6 ± 76.77 263.9 ± 76.77 116.1 ± 75.88 0.240 0.074 
HP NL 20.9 ± 3.39b 24.7 ± 3.17ab 30.1 ± 3.17a 23.0 ± 3.09 0.041 0.966 
Brain accretion, PL4 5359 ± 3582.5 6078 ± 3324.2 10706 ± 3324.2 5556 ± 3364.9 0.310 0.073 
Brain accretion, NL4 868 ± 131.2b 997 ± 120.5ab 1215 ± 120.5a 1053 ± 120.5 0.084 0.813 
RBC PL5 92.94 93.26 94.97 95.49 - - 
RBC NL5 7.06 6.74 5.03 4.51 - - 
HP PL5 28.45 24.82 28.44 37.61 - - 
HP NL5 71.55 75.18 71.56 62.39 - - 
a-b Means within a row lacking a common superscript letter differ (P < 0.05). 
1Phospholipid and neutral lipid concentrations (µg/g tissue) of DHA from hippocampal tissue and RBC. Data are presented as mean ± SEM.  
2Experimental treatments include AR (T1-T3) groups. T1, AR control; T2, PDF; T3, PDF + lecithin + cholesterol. Reference values obtained from SR piglets 
were not included in the statistical analysis when comparing treatments.  
3Abbreviations: RBC, red blood cell; HP, hippocampus; PL, phospholipid; NL, neutral lipid.  
4Brain accretion calculated from µg/g tissue * absolute whole brain weight (g) at 27 d of age.  
5Values depict percentage of DHA accretion in the PL and NL fractions as a proportion of DHA present in both fractions combined.  
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Table 3.6 Percentage of fat in fecal samples from artificially-reared (AR) and sow-reared (SR) piglets1 
 Experimental Treatment2 P-value 
Item T1 T2 T3 SR Reference
3 Treatment Sex 
n 5 10 10 8   
Fecal dry matter, % 38.5 ± 3.50 40.6 ± 2.73 38.3 ± 2.73 54.3 ± 1.33 0.813 0.539 
Fecal organic matter, % 88.2 ± 1.08a 86.0 ± 0.89ab 85.1 ± 0.89b 88.4 ± 0.58 0.037 0.929 
Fecal fat, % DM 35.8 ± 4.89 47.6 ± 3.66 49.2 ± 3.66 68.1 ± 2.52 0.058 0.298 
Fecal fat, % OM 40.5 ± 5.35b 55.3 ± 3.96a 57.7 ± 3.96a 77.2 ± 3.19 0.029 0.303 
a-b Means within a row lacking a common superscript letter differ (P < 0.05). 
1Percentage of acid-hydrolyzed fat and organic matter (OM) in fecal matter. Samples were collected from d 13-17 of study and pooled for all analyses. Data 
are presented on a dry matter (DM) basis as means ± SEM.  
2Experimental treatments include AR (T1-T3) groups. T1, AR control; T2, PDF; T3, PDF + lecithin + cholesterol. Reference values obtained from SR piglets 
were not included in the statistical analysis when comparing treatments.  
3Reference values obtained from sow-reared animals that were not part of this study.  
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w e re  n o t  in c lu d e d  in  th e  s ta t i s t ic a l  a n a ly s is  w h e n  c o m p a r in g  t re a tm e n ts .
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Chapter 4 
COMPARISON OF BRAIN DEVELOPMENT IN SOW-REARED AND 
ARTIFICIALLY-REARED PIGLETS 
Abstract 
Provision of nutrients immediately following birth is critical for proper growth and 
development of the neonate, but the impact of nutritional composition of breast milk on neural 
maturation has yet to be determined. Using the piglet as a model for the human infant, our 
objective was to compare maternal sow’s milk with artificial formula on postnatal 
neurodevelopmental patterns. Over a 25-day feeding study, piglets (n=9-10 per treatment, 1.5 ± 
0.2 kg initial BW) were either sow-reared (SR) with ad libitum intake, or artificially-reared (AR) 
receiving 1 of 3 milk replacers modified to mimic the nutritional profile and intake pattern of 
sow’s milk. Our AR treatments included: T1, artificially-reared (AR) control formula; T2, T1 + 
45% total dietary fat replaced with pre-digested fat (PDF); T3, T2 + 10% lecithin + 0.4% 
cholesterol. At study conclusion, piglets were subjected to a standardized set of magnetic 
resonance imaging (MRI) procedures to quantify structure and composition of the brain. 
Diffusion tensor imaging, an MRI sequence that characterizes brain microstructure, revealed that 
SR piglets had greater (P < 0.05) average whole-brain fractional anisotropy (FA) values 
compared with AR piglets, suggesting differences in white matter organization. Although global 
analysis did not reveal differences within AR treatments for DTI outcomes,  FA values of the 
internal capsule were not different between SR and T3-fed piglets, suggesting a modulatory 
effect of PDF + lecithin + cholesterol fat system on white matter maturation. Voxel-based 
morphometric analysis, a measure of white and grey matter volumes, revealed differences (P < 
0.05) in bilateral development of grey matter clusters in the cortical brain regions of the AR 
piglets compared with SR piglets. Region of interest (ROI) analysis revealed larger (P < 0.05) 
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whole brain volumes in SR animals compared with AR, and subcortical regions to be larger (P < 
0.05) as a percentage of whole-brain volume in AR piglets compared with SR animals. 
Quantification of brain metabolites using magnetic resonance spectroscopy revealed SR piglets 
had higher (P < 0.05) concentrations of myo-inositol, N-acetylasparate + N-
acetylaspartylglutamate, glycerophosphocholine + phosphocholine, and creatine + 
phosphocreatine compared with AR piglets. Overall, increases in these metabolite 
concentrations, coupled with greater FA values in white matter tracts and volume differences in 
grey matter of specific brain regions, suggest greater myelin development and cell proliferation 
in SR vs. AR piglets.  
 
Introduction 
Early-life nutrition, whether provided as breast milk, infant formula, or the combination, 
may influence structural development, as well as cognitive and behavioral development of the 
child. Epidemiological findings suggest a positive impact of breastfeeding on motor, problem 
solving and personal-social outcomes when controlling for confounding variables (1). An 
increasing number of neuroimaging and cognitive studies positively correlate consumption of 
breast milk (BM) and duration of breastfeeding with macro- and microstructural maturation of 
the infant brain, along with improved performance on cognitive testing in adolescence (2,3). The 
brain is only second to adipose tissue in lipid content, hence the high concentration of n-3 long 
chain polyunsaturated fatty acids (LCPUFA) in breast milk is considered to be highly influential 
in infant brain development (4). Specifically, docosahexaenoic acid (DHA) is a notable n-3 
LCPUFA hypothesized to drive the enhanced impact of BM on the structural integrity and 
cognitive development of the infant brain. As a structural component of the neuronal plasma 
membrane, DHA is highly incorporated into glycerophospholipids, and may play a role in 
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maintaining integrity of electrical activity within the neuron. Concentration of BM DHA varies 
according to maternal diet, but an average concentration of 0.2-0.3 g of DHA/100 g of total fatty 
acids has been noted in North American, European and Australian women (5,6). Due to its 
neuro-augmenting nature, DHA was approved as an additive to infant formula in 2002 at 
concentrations similar to those found in BM (7,8). Despite the length of time DHA has been 
supplemented in infant formulas, it is surprising that the impact of added DHA on infant brain 
development is not yet fully understood. 
Neuroimaging techniques employed to assess brain development include diffusion tensor 
imaging (DTI), magnetization prepared rapid gradient-echo (MPRAGE) sampling, and magnetic 
resonance spectroscopy (MRS). Diffusion tensor imaging is a noninvasive method to assess 
spatial organization and degree of myelination of white matter tracts in the infant brain. The four 
quantitative measures used in DTI to assess free water diffusion include mean diffusivity (MD), 
axial diffusivity (AD), radial diffusivity (RD), and fractional anisotropy (FA). Mean diffusivity  
represents a holistic picture of water diffusivity in the brain (9). Fractional anisotropy assesses 
the rate and directionality of water diffusivity with in the axonal microenvironment (10). 
Additionally, AD and RD rates represent diffusion along and across a fiber orientation, 
respectively, as averaged components of MD. Structural MRI (i.e., MPRAGE) sequences allow 
for quantification of not only regional volumes, but also grey and white matter volumes, on a 
voxel-by-voxel basis (11). Lastly, MRS generates a representation of the chemical makeup of the 
developing brain (12). Each of these measures provides distinct information including neuronal 
maturation, structural development, and the metabolic profile of the developing brain.  
The AR piglet has previously been established in the field of nutritional neuroscience as a 
relevant translational model for the human infant (13–16). However, to our knowledge, 
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normative brain development in the SR animal has yet to be characterized. Human neuroimaging 
research is well ahead of biomedical research in this sense, where the maternally-fed infant has 
long been identified as the normative standard for brain development against which all other 
developmental trajectories are measured. Due to the lack of a similar standard in piglet research, 
a primary objective of this study was to establish the neurodevelopmental trajectory of the SR 
piglet. Characterization of a normative standard for neurodevelopment in SR piglet will 
strengthen the model, thereby allowing for current and future conspecific comparisons for 
structural, functional and cognitive processes. As a secondary objective, nutritional strategies 
designed to align the lipid composition of human infant formula with that of sow’s milk were 
tested. 
Overall, using the piglet as a translational model for the human infant, this study aims to 
use clinically-relevant MRI techniques to assess the impact of maternal milk and artificial 
formula on brain development. Three groups of AR piglets consuming human infant formulas 
modified for the piglet, each with a novel lipid product, were compared with SR piglets.   
Materials and Methods 
Animals, Housing, and Feeding  
Naturally-farrowed piglets (n=10/treatment, 1.5 ± 0.2 kg initial BW; sourced from 10 
sows, n=2/treatment from each sow) were obtained from the Imported Swine Research 
Laboratory herd located at the University of Illinois. Piglets were allowed access to colostrum 
for up to 48 h, at which point they were allotted to one of 4 experimental treatments for the 
duration of a 25-d feeding study (conducted using 5 cohorts of piglets). Piglets were housed 
individually in stainless steel cages (101.6 cm L x 76.2 cm W x 81.28 cm H), and were provided 
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with a towel and toy (Bio-Serv, Flemington, NJ) for comfort and environmental enrichment. 
Cages were fitted with vinyl-coated expanded-metal flooring (Tenderfoot/NSTM), which was 
designed for neonatal piglets, and were also outfitted with a heat lamp and electric heat mat 
(K&H Manufacturing, Colorado Springs, CO) to maintain home cage temperatures between 23-
31°C. A 12-h light/dark cycle was maintained with minimal light provided during dark cycles for 
the duration of the study.  
Artificially-reared animals were fed 1 of 3 isocaloric dietary treatments as follows: T1, 
AR control formula; T2, T1 + 45% total dietary fat replaced with pre-digested fat (PDF); T3, T2 
+ 10% lecithin + 0.4% cholesterol. Sow reared animals (T4) remained with their respective 
mother and litter mates for the duration for the study (Table 3.1). Artificially-reared piglets were 
fed using an automated feeding system that dispensed a pre-determined volume of formula over 
a period of 13 ± 2 h based on daily BW of piglets. The diets were replaced twice daily and were 
dispensed from 6 identical reservoirs that were cleaned and sterilized daily. Piglets were fed 285 
ml/kg BW, 300 ml/kg BW, and 325 ml/kg BW from 0-7, 8-16, and 18-25 d on study, 
respectively.  
 Per agricultural protocols, all piglets were identified at birth using ear notches, needle 
teeth were removed to prevent harm to littermates and the sow. Moreover, piglets received a 
supplemental iron injection at 1 d of age, but did not undergo other agricultural processing (i.e., 
tail docking and castrations). Approximately 5 ml of clostridium perfringens antitoxin C + D 
(Colorado Serum Company, Denver, CO) was administered subcutaneously as a prophylactic 
agent at d 2 of age. If piglets developed diarrhea, supplemental water and electrolytes (Pedialyte, 
Abbott Laboratories, Abbott Park, IL) were provided. Sulfamethoxazole and trimethroprim oral 
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suspension (50 and 8 mg/mL, respectively, Hi-Tech Pharmacal, Amityville, NY) were given if 
symptoms were not alleviated after 48 h of exhibiting initial symptoms.  
Magnetic Resonance Imaging 
Magnetic Resonance Imaging and Anesthesia Overview 
All piglets underwent magnetic resonance imaging (MRI) procedures at 21 ± 2 d of age 
at the Beckman Institute Biomedical Imaging Center using a MAGNETOM Trio 3 Tesla magnet 
with a Siemens 12-channel head coil. These sequences included magnetization prepared rapid 
gradient-echo (MPRAGE) and diffusion tensor imaging (DTI) to assess brain macrostructure and 
microstructure, respectively, as well as magnetic resonance spectroscopy (MRS) to obtain brain 
metabolite concentrations. In preparation for MRI procedures, anesthesia was induced using an 
intramuscular injection of telazol:ketamine:xylazine administered at 0.022 mL/kg BW, and 
maintained with inhalation of isoflurane (98% O2, 2% isoflurane). Piglets were immobilized 
during all MRI procedures. Visual observation of a subject’s well-being, as well as observations 
of heart rate, PO2 and percent of isoflurane were recorded every 5 minutes during the procedure, 
and every 10 minutes post-procedure until animals recovered. Total scan time for each pig was 
approximately 60 minutes.  
Structural MRI Acquisition and Analysis 
 A T1-weighted MPRAGE sequence was used to obtain anatomic images of the piglet 
brain. Three repetitions were acquired using the following parameters: repetition time (TR) = 
1900 ms; echo time (TE) = 2.49 ms; inversion time= 900 ms; flip angle = 9°; matrix= 256 x 256; 
slices = 224; slice thickness = 0.7mm; voxel size=0.7mm x 0.7mm x 0.7mm. Three MPRAGE 
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data sets from each animal were averaged, and brains were manually extracted using FMRIB 
Software Library (FSL) (FMRIB Centre, Oxford, UK). Images were realigned using an affine 
transformation to the same stereotactic space using SPM8 in MATLAB 8.3 with a publically 
available, population-averaged piglet brain atlas generated by Conrad et al., 
(www.pigmri.illinois.edu). This process minimized mean square differences between the 
template and individual sample brains, and aligned position and size of individual images to the 
atlas. 
To complete morphometric analysis of grey and white matter volumes on a voxel-by-
voxel basis, GM, WM and cerebrospinal fluid (CSF) were segmented using a tissue probability 
mask established by the piglet brain atlas. Using a diffeomorphic anatomical registration through 
exponentiated lie algebra (DARTEL) toolbox in SPM8, an average of all individual brains was 
obtained to generate an initial study-specific template brain used for registration and spatial 
normalization of individual brains. Spatial normalization refers to a registration method which 
allows for warping of images from multiple subjects into the same standard space. This process 
essentially allows for signal averaging across subjects and corrects for global differences in 
overall brain shape. Changes from default include a bounding box of -30.1 to 30.1, -35 to 44.8, -
28 to 31.5; and a voxel size of 0.7 mm3. A linear bend energy was used as a cost function, and a 
4-mm full-width half maximum (FWHM) smoothing operation was then imposed on the 
modulated data.    
The statistical non-parametric methods (SnPM) toolbox was used to compare modulated 
grey and white matter data between treatment groups. A designation of 5000 non-parametric 
permutations were used with a 7-mm FWHW for variance smoothing; ANCOVA was used for 
global normalization and a mean voxel value was used for global calculation. No covariates were 
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used, and all other default options were employed. A cluster-level threshold of at least 20 voxels 
was set, and voxel clusters at the edge of the brain were excluded. Grey and white matter volume 
differences between treatments were presented in tabulated form with pseudo-t values indicating 
level of significance, with estimated anatomic regions, as well as the Cartesian coordinate 
system, indicating an estimated center of significant voxel clusters. Data are also presented as 
heat maps with corresponding pseudo-t-values. Specific anatomic regions were estimated based 
on the Saikali atlas of the adult pig, which employed histology to identify individual brain 
regions (17).  
 Flow fields generated during the DARTEL procedure were converted to warp fields. The 
inverse of these warp fields represented a quantifiable amount of shrinkage or expansion of an 
individual subject’s brain in comparison to the study-specific atlas. The inverse warp fields were 
applied to individual brains to estimate structural volumes for 19 regions of interest. Inverse 
warps were applied to the region of interest (ROI) maps previously established with the piglet 
brain atlas, and used brain region volumes in FSL stats.  
Diffusion Tensor Imaging Acquisition and Analysis 
Diffusion tensor imaging (DTI) was used to assess white matter maturation and axonal 
tract integrity. Specifically, a diffusion-weighted, echo-planar imaging (DW-EPI) sequence was 
used with the following parameters: repetition time (TR) = 5000 ms; echo time (TE) = 91 ms; 
average = 3; diffusion weightings = 2; b value = 1000 s/mm2 across 30 directions, two images 
with b-value of 0 s/mm2; slices = 40, slice thickness = 2.0 mm; final voxel size = 2.0 mm 
isotropic. 
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Diffusion-weighted EPI images were assessed in FSL for fractional anisotropy (FA), 
mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD). Diffusion tensor 
imaging datasets were manually extracted using standardized procedures. Next, masks for all 
ROI from the piglet atlas were non-linearly transformed into the subject’s MPRAGE space. 
These ROI were then brought into the DTI space using a linear transformation procedure, and a 
threshold of 0.15 applied to correct for expansion caused by interpolation. A threshold of 0.5 was 
applied to known WM segmentation from the MPRAGE sequence and the entire dataset was 
dilated twice. Average FA values were obtained for these regions with threshold of 0.2 to ensure 
that only WM was included in the analysis.   
Magnetic Resonance Spectroscopy Acquisition and Analysis 
Magnetic resonance spectroscopy was used to non-invasively quantify metabolites in 
both hippocampi, and in intervening tissue. The MRS spin-echo chemical shift sequence was 
used with the following parameters: repetition time (TR) = 3000 ms; echo time (TE) = 30 ms; 
average = 128; voxel size = 12 mm x 25 mm x 12 mm centered over the left and right dorsal 
hippocampi. Both water-suppressed and non-water-suppressed data were collected in 
institutional units, and all MRS data were analyzed using LC Model (version 6.3). There were 
two limits placed on MRS data for inclusion in the statistical analysis. Cramer-Tao lower bounds 
(i.e., % standard deviation) were calculated using the LC Model, and only metabolites with 
standard deviation less than 20% were considered to have reliable quantitative results of absolute 
levels. In addition, metabolites included in the analysis were identified in at least 4 subjects per 
treatment. Metabolite concentrations were expressed in absolute and as a proportion of creatine 
values, but absolute concentrations were used for statistical analysis as creatine levels fluctuated 
over treatment groups.  
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Statistical Analysis 
Overall, numerical data obtained from DTI and MRS sequences were subjected to an 
analysis of variance (ANOVA) using the MIXED procedure in SAS v 9.4. Replicate cohort of 
pigs was included as a random variable, and the threshold of significance was set at P < 0.05. 
Data collected from a single time-point were analyzed using a one-way ANOVA, and two-
sample permutation t-tests were performed to assess differences in MRI outcomes between 
individual treatments when appropriate. Two-sample permutation t-tests were performed on a 
voxel-by-voxel basis for grey and white matter volume differences between all AR and SR 
animals with an uncorrected P < 0.001, and between individual AR treatments with an 
uncorrected P < 0.01. Data analysis of ROI volume, DTI components, and metabolite 
concentrations estimations for effect of treatment and sex were conducted using a two-way 
ANOVA in MIXED procedure of SAS 9.4. Data are presented as means ± standard error of the 
mean (SEM) with significance accepted at P < 0.05. 
Results 
Details regarding growth performance, metabolic and intestinal development outcomes 
associated with this study have previously been discussed (Figures 3.1-3.3, Tables 3.1-3.6). 
Magnetization-Prepared Rapid Acquisition Gradient Echo 
Voxel-based morphometry 
Voxel-based morphometric analysis largely revealed effects due to rearing environments.  
Of the significant voxel clusters identified, those located in the right and left cortex with pseudo-t 
values of 7.98, 6.54 and 5.33 were estimated in accordance with given x, y and z coordinates to 
be located in the insular cortex (Figure 4.1, Table 4.1). In contrast, WM volume comparison of 
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SR > AR treatments showed pseudo-t values to be highest in regions located in the olfactory 
bulbs of the right and left cortices. The following intra-treatment comparisons between AR 
piglets were also conducted for GM and WM volumes with threshold for statistical significance 
set at P = 0.01: T1 vs. T2 (Figure 4.2, Table 4.2), T1 vs. T3 (Figure 4.3, Table 4.3) and T2 vs. 
T3 (Figure 4.4, Table 4.4).  
Estimated ROI volumes 
 Estimation of absolute whole-brain volumes were higher (P < 0.001) in SR animals 
compared to their AR counterparts (Table 4.6). However, the incidence at which ROI differed 
between AR and SR groups decreased, and effects due to sex were more frequently significant, 
when ROI volumes were expressed as a percent of total brain volume (TBV) (Table 4.7). 
Overall, as a percent of TBV, total hippocampal volume, as well as left and right hippocampal 
volumes expressed separately, were smaller (P < 0.05) in SR piglets compared to their AR 
counterparts. Ventricular system components including the cerebral aqueduct, fourth ventricle, 
lateral ventricle and third ventricle were also smaller (P < 0.05) as a percent of TBV in SR 
piglets, with no significant difference in fourth ventricle volume between T3-fed AR piglets and 
SR piglets. Other ROI including caudate, midbrain and pons were smaller (P < 0.05) as a percent 
of TBV in AR piglets when compared with SR piglets. Volumes of specific ROI including GM, 
WM, left/right cortex, corpus callosum, caudate, hypothalamus, internal capsule, olfactory bulb, 
putamen and thalamus were larger (P < 0.05) as a percent of TBV in female piglets when 
compared with males.  
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Diffusion Tensor Imaging  
Average FA values of whole-brain, WM, internal capsule (IC), and right cortex were  
higher (P < 0.05) in SR piglets compared with AR piglets, with no significant differences 
between AR treatments (Table 4.8). Fractional anisotropy of the IC was higher (P < 0.05) in SR 
animals when compared with AR piglets fed either T1 or T2, but no differences were observed 
between T3 and SR piglets. Average hippocampal FA of female piglets was higher (P < 0.05) 
when compared with their male counterparts. Whole brain MD (Table 4.10) and RD (Table 
4.11) values were lower (P < 0.05) in SR animals when compared with AR animals, with no 
differences observed between AR treatments. Axial diffusivity (Table 4.9) of whole-brain was 
lower (P < 0.05) in SR piglets when compared with AR piglets, and higher (P < 0.05) in the IC 
for SR piglets when compared with AR piglets fed T2. A main effect of sex was detected in the 
right hippocampus, with female piglets exhibiting higher (P < 0.05) AD and MD values 
compared with male piglets. 
Magnetic Resonance Spectroscopy 
Absolute concentrations of nine metabolites were quantified, with creatine + 
phosphocreatine (CR-PCR), glycerophosphocholine + phosphocholine (GPC-PCH), myo-
inositol (INS), and N-acetylaspartate + N-acetylaspartylglutamate (NAA-NAAG) affected (P < 
0.05) by treatment (Table 4.12). Concentrations of CR-PCR were higher (P < 0.05) in SR 
animals when compared with all AR treatments, with no differences detected between AR 
treatments. Absolute concentrations of GPC-PCH were higher in SR animals compared with AR 
piglets, with higher GPC-PCH concentrations detected in T3- vs. T2-fed piglets. Piglets fed T3 
exhibited INS concentrations that were not different from SR animals, with the highest values 
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present in SR piglets and no differences between animals fed T1 or T2. Finally, concentrations of 
NAA-NAAG were higher (P < 0.05) in T3- vs. T2- and T1-fed animals, and there were no 
differences present between T1- and T2-fed AR piglets, nor T1 and SR animals.  
Discussion 
Using the piglet as a biomedical model, this study sought to investigate the impact of 
manipulating the dietary fat matrix found in infant formula on macro- and micro-structural 
development of the neonatal piglet brain. Artificially-reared animals were raised individually and 
fed 1 of 3 isocaloric dietary treatments, while SR animals remained with the dam and littermates 
for duration for the study. Global analysis indicated a steeper neurodevelopmental trajectory in 
SR animals as characterized by larger whole-brain volumes, higher FA values (indicating greater 
white matter maturation and myelination of axonal tracts), as well as elevated concentration of 
metabolites linked to myelin synthesis. Similarities in diffusion characteristics were observed 
between SR and T3-fed piglets in early-maturing regions, such as the internal capsule, indicating 
a modulatory effect of the PDF, lecithin and cholesterol fat system on white matter maturation. 
Furthermore, subcortical region volumes, expressed as proportion of whole-brain volume, were 
higher in AR animals, suggesting that subcortical regions are preferentially developing in the 
formula-fed animals at 3 weeks of age.   
Region of Interest Volumes  
Assessment of absolute brain volumes suggested larger brains in SR vs. AR piglets, with 
little evidence of sexually-dimorphic effects. Because previous studies have revealed variations 
in brain development in male and female piglets of this age group (18), we chose to express ROI 
volumes relative to whole-brain volume. As a percentage of TBV, AR piglets possessed 10 ROI 
volumes that were different compared with SR piglets. Regions of interest including the left and 
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right hippocampi, caudate, midbrain, pons, cerebral aqueduct, as well as the fourth, lateral and 
third ventricles were all proportionally smaller in SR animals when compared with AR animals. 
When totaled and averaged over all AR treatments, these ROI volumes were 5.81 percentage 
units larger, as a proportion of TBV, in the AR piglet than in the SR animal. Primarily localized 
to the subcortical regions, these ROI were mainly sequestered to the limbic system and brain 
stem, where they are responsible for regulating the most fundamental physiological processes 
within the brain. Considering that functional hierarchy determines preference for structural 
development in the neonatal brain (19), we propose that despite a deficit in whole-brain volumes, 
we still see conserved development of these subcortical regions in piglets fed artificial formula as 
compared to the SR piglets. Considering whole-brain volumes were considerably smaller in AR 
animals, compared with their SR counterparts, we expected a decrease in cortical size as a 
percentage of TBV, but no differences between AR treatments were observed in cortical 
development. Furthermore, cortical volumes as a proportion of whole-brain volume remained 
numerically higher in AR animals. This leads us to believe that the volume dedicated to 
cerebrospinal fluid (CSF) may be smaller in AR animals compared with SR piglets, but this 
finding has yet to be corroborated.  
Typical patterns of postnatal neurodevelopment in healthy infants follow a predictable 
trajectory, which include competitive elimination of neurons and myelination of axonal tracts 
(20). Pruning or competitive elimination refers to environmentally regulated changes in the 
density of synapses per unit of dendritic length, as well as axonal pruning (21). Pruning seems to 
facilitate higher order functioning in humans (22), and typical patterns of neurodevelopment 
dictates that large scale synaptogenesis, followed by pruning of non-established connections, 
occurs before large scale myelination (22). In our study, relative whole-brain GM volume was 
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numerically lower in SR animals when compared with AR piglets. However, whole-brain FA of 
SR animals remained higher despite this reduction in GM volume. Such correlation between a 
reduction in GM volume and increase in FA may indicate greater levels of myelination of the 
axons in the SR animal. Our interpretation of these data remains speculative, however, as we did 
not directly assess pruning in our study, and our observations do not fall in line with biological 
timelines of pruning observed in humans (18,23).  
Voxel-based Morphometry 
Voxel-based morphometric analysis revealed volumetric differences in both GM and 
WM between SR and AR groups. Overall, we observed highly-significant differences in GM 
volume in the frontal-cortical regions of AR animals, while greater WM volumes were revealed 
in the olfactory areas of SR animals. Most significant GM clusters observed in AR piglets were 
located bilaterally in the rostral part of the brain. The Saikali atlas estimates that these clusters 
are localized to the insular cortex (17). The anterior insular cortex is described as an “integrative 
hub” which processes and directs incoming physiological signals, and is considered a juncture 
for cognitive and emotional processes (24). Moreover, this region may influence response 
inhibition of the pre-frontal cortex and activation of the striatum during reward anticipation (25). 
Similar trends were observed in WM volume of the insular cortex of the left cortex in piglets. As 
such, the combined higher GM and WM volumes of the insular cortex may indicate greater 
structural maturity of these regions in AR animals compared with SR piglets.   
 In SR animals, evidence of highest WM maturation appeared to be localized to the right 
cortex in the piglet atlas, however, significance was also observed in the somatosensory 
association cortex, geniculate nuclei, and premotor cortex of the piglet brain based on the Saikali 
atlas. The somatosensory association cortices integrate somatosensory and visual inputs and 
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allow improved processing of tactile information (26). Integration of multiple sensory modalities 
(i.e., touch and sight, or touch and hearing), as well as projections to brain regions in the medial 
temporal lobe, including the entorhinal and perirhinal cortices and hippocampus, are facilitated 
by the somatosensory association cortex (27). An increase in WM in this region may suggest a 
more mature neural network, but such assessments are not fully possible without functional or 
behavioral outcomes as corroborative evidence. 
Diffusion tensor imaging  
Diffusion tensor imaging was used to characterize the organization and structural 
integrity of axonal tracts in the piglet brain. Fractional anisotropy, MD, AD and RD values 
obtained through DTI techniques provide distinct information regarding WM integrity, and these 
complementary measures are interdependent in accurately quantifying brain development. 
Higher FA values of the whole brain, WM, internal capsule, and right cortex of piglets suggested 
that axonal tract maturity and degree of myelination was highest in SR animals compared with 
their AR counterparts. These data are consistent with the human literature, which suggests a 
positive relationship between breastfeeding and development of early-maturing WM regions 
such as the corpus callosum, internal capsule, corticospinal tract, cerebellum and left optic 
radiation (2). Extended breast-feeding has also been shown to correlate with myelination in 
regions associated with language acquisition, sensory motor development, and motor control (2). 
In human infant studies, both transverse and parallel diffusivity of free water in early-
maturing fiber bundles, such as those found in the internal capsule, are low and accompanied by 
higher FA values compared with those found in late-maturing subcortical projection and 
association tracts (28). An increase in FA, partnered with a reduction in free water diffusivity, 
indicate increased axonal density, pre-myelination, and myelination of established axonal tracts 
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(29). Of the regions of interest assessed in our study, FA values of the internal capsule were 
highest, indicating a similar pattern of preferential commissural WM tract development in the 
piglet when compared with the human infant. In the human infant, myelination is visible in the 
internal capsule by approximately 3 months of age (30), which correlates with the approximate 
age at which the piglets underwent MRI. These data further support previously established 
neurodevelopmental trajectories between the two species (18,23). In addition, the lack of 
difference in internal capsule FA values between T3-fed and SR animals may suggest the diet 
directly influences incorporation of LCPUFA in the brain, which may subsequently alter WM 
maturation.  
Magnetic Resonance Spectroscopy   
Magnetic resonance spectroscopy provides a measurement of brain metabolites that serve 
as biomarkers for metabolic efficiency, energy storage, inflammation, structural integrity, and 
brain integrity (31). Our data reveal CR-PCR concentrations to be higher in SR piglets when 
compared with AR piglets, and unbound CR concentrations to be numerically lower in T1 and 
T4 piglets, compared to T2 and T3 piglets. However, it is only in SR piglets that the decrease in 
unbound CR is compensated for through an increase in phosphate bound CR. The primary role 
for CR-PCR consist of storing and distributing phosphate-bound energy and serving as a buffer 
system during low ATP:ADP status (31). During a low energy state, phosphate-bound PCR is 
paired with ADP, and a phosphate is transferred to ADP to generate CR and ATP. In high energy 
states, the reverse reaction occurs. Higher levels of phosphate bound CR, when partnered with 
trends for lower free CR, may indicate higher energy stores in the SR piglets when compared 
with AR piglets.  
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N-acetylaspartate is the most abundant metabolite present in the brain, and is heavily 
involved in oxidative metabolism and myelination. Precursors of NAA are abundantly present 
when the energy requirements of the cell are met, indicating stability in ATP production and 
metabolic efficiency(31). N-acetylaspartate is also used to generate myelin precursors in the 
neuron, and higher concentrations of NAA have been correlated with higher FA values, 
indicating improved axonal tract integrity, an indirect measure of myelination (31,32). Although 
our data suggests differences between treatments in NAA-NAAG concentrations, the lack of 
differences in hippocampal FA values precludes us from correlating NAA concentrations with 
myelination of hippocampal axons. Myo-inositol cannot cross the blood brain barrier and is 
primarily synthesized in glial cells, and is therefore considered to be a marker of glial cell 
proliferation and size (33). No differences in myo-inositol were detected between SR and T3-fed 
animals, suggesting a similar rate of astrocyte proliferation in these treatment groups.  
The substantial role of DHA in maintaining the structural integrity of neuronal plasma 
membranes (34) lead us to assess whether accretion of DHA within neural tissue correlate with 
comparable developmental patterns of cortical and subcortical regions in AR and SR animals. 
Although differences in subcortical ROI volumes as a percentage of TBV were discussed in 
detail, neither the impact of predigestion of dietary fat, nor the  supplementation of lecithin and 
cholesterol on these outcomes have yet to be discussed. Resistance to dietary nutrient deprivation 
in hippocampal accretion of PUFA, particularly that of DHA, has been observed in rodents (35). 
As a separate component of this study, DHA accretion in the hippocampus is higher in piglets 
fed the PDF system supplemented with lecithin and cholesterol. Animals fed T3 also express 
lowest numerical variations from subcortical ROI volumes, as percent of TBV, observed in SR 
animals.  Similarities are present in T3 and T4-fed piglets in white matter maturation of the 
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internal capsule and in hippocampal NAA+ NAAG concentrations. These results are indicative 
of a positive effect of PDF + lecithin + cholesterol fat system on overall brain development as 
assessed by MRI techniques.  
To our knowledge, this study is the first of its kind to characterize neurodevelopmental 
patterns of the SR piglet. Although only a single time-point in the invariably changing neonatal 
neural network was studied, these data provide a foundation for establishing the SR piglet as a 
biomedical species for studying nutritional neuroscience. Overall results of this study suggest SR 
piglets experience greater WM maturation at 3 weeks of age compared with AR counterparts. 
Behavioral assessments are required to ascertain functional implications of the variations in brain 
macro and microstructure, these data could lay a foundation for future nutritional neuroscience 
research using the piglet.  
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Tables 
Table 4.1. Comparison of white matter cluster volumes between artificially-reared (AR) and sow-reared (SR) piglets1 
Tissue Comparison Anatomic Region 
Cluster 
(voxels) 
Cluster level      
(P-value) 
x y z Pseudo-t Saikali ROI2 
White Matter 
SR>AR 
Right cortex 3 522 0.0008 10 10 15 5.66  
Right cortex 1211 0.0002 3 34 1 5.45  
Left cortex 191 0.0006 -10 6 17 4.93 Somatosensory association 
cortex Thalamus 94 0.0004 -8 -1 -1 4.68 Geniculate nuclei 
Olfactory 272 0.0006 4 23 -8 4.34  
Right cortex 22 0.0008 6 20 15 3.27 Premotor cortex 
Undefined 24 0.0006 1 -27 -8 0.09  
Total voxels 2336       
AR>SR 
Right cortex 1553 0.0002 17 20 10 6.05  
Left cortex 1863 0.0002 -15 24 10 5.90 Insular cortex 
Left cortex4  0.0002 -7 28 13 3.23 Primary somatosensory 
cortex Cerebellum 80 0.0006 -7 -15 -1 5.37  
Internal capsule 117 0.0002 7 13 6 5.17  
Undefined 285 0.0008 -6 15 5 5.00 Caudate nucleus 
Right cortex 348 0.0006 10 9 -5 4.96  
Right cortex 514 0.0002 14 -18 6 4.39 Crus 2 of the ansiform lobule 
Midbrain 224 0.0002 0 -2 -5 4.11  
Internal capsule 77 0.0004 10 8 3 4.10  
Midbrain 79 0.0008 5 -5 3 2.68  
Right cortex 483 0.0008 13 30 9 2.62  
Medulla 252 0.0008 2 -12 -17 2.61  
Undefined 28 0.0006 -4 -4 4 2.41  
Cerebellum 31 0.0008 -4 -18 4 2.26 Cerebellar lobule VI 
Right cortex 50 0.0008 6 16 19 1.42 Primary motor cortex 
Total voxels 4431       
Clusters > 20 were included in analysis with threshold set at P < 0.001. 
1Experimental Treatments include AR (T1-T3) and SR groups. T1, AR control; T2, PDF; T3, PDF + lecithin + cholesterol; T4, SR control.                                                                                 
2References the Saikali pig brain atlas which provides more detailed estimation of structures with in cortical regions (17). 
 3Data in this table should be read as follows: 522 voxels in the left cortex contain greater white matter volume in SR pigs in comparison to AR pigs. The 
center voxel in cluster is located at coordinated 10, 10, and 15 on the x, y, and z plane. Cluster level P = 0.0008 refers to uncorrected P-value associated with 
pseudo-t value of 5.66.  
4Missing cluster value is contiguous with voxel cluster listed immediately above, and represents 1 of 2 continuous voxel clusters with 2 different center voxels.  
F>S White 
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Table 4.2. Comparison of gray matter cluster volumes between artificially-reared (AR) and sow-reared (SR) piglets1 
Tissue Comparison Anatomic Region 
Cluster 
(voxels) 
Cluster level        
(P-value) 
x y z Pseudo-t Saikali ROI2 
Gray Matter 
SR>AR 
Right cortex 657 0.0002 14 3 10 5.44  
Right cortex  0.0008 10 12 13 3.07  
Olfactory 417 0.0004 -4 25 -8 5.29  
Undefined 85 0.0002 -9 8 -4 5.26  
Right cortex 356 0.0004 10 7 -6 5.26 Hippocampus 
Cerebellum 398 0.0002 2 -23 4 5.20  
Undefined 1032 0.0008 6 34 -1 5.06 Anterior prefrontal cortex 
Cerebellum 149 0.0008 -7 -20 0 4.18 Lateral cerebellar nucleus 
Left cortex 203 0.0002 -4 24 3 3.96 Caudate nucleus 
Left cortex 164 0.0004 -12 4 10 3.88  
Undefined 74 0.0006 5 24 4 3.69 Caudate nucleus 
Medulla 60 0.0008 3 -22 -15 3.62  
Cerebellum 24 0.0008 9 -20 -2 3.03  
Total voxels  3619       
AR>SR 
Right cortex 2149 0.0002 17 14 10 7.98 Insular cortex 
Left cortex 1619 0.0002 -16 14 10 6.54 Insular cortex 
Left cortex3  0.0004 -13 24 8 5.33 Insular cortex 
Caudate 469 0.0008 5 10 7 4.82  
Left cortex 272 0.0002 -17 -1 -4 4.49 Anterior entorhinal cortex 
Right cortex 148 0.0004 3 24 13 4.29 Dorsal anterior cingulate 
cortex Right cortex 463 0.0008 6 17 17 4.04 Premotor Cortex 
Left cortex 315 0.0002 -4 19 17 4.01  
Left cortex 97 0.0008 -17 6 14 3.51 Insular cortex 
Left cortex 56 0.0002 1 10 15 3.36 Dorsal posterior cingulate 
cortex Right cortex 90 0.0002 21 -5 5 3.02  
Undefined 53 0.0004 -10 -2 8 2.88 Third ventricle 
Right cortex 23 0.0008 20 5 13 2.74  
Total voxels  5754       
Clusters > 20 were included in analysis with threshold set at P < 0.001. 
1Experimental Treatments include AR (T1-T3) and SR groups. T1, AR control; T2, PDF; T3, PDF + lecithin + cholesterol; T4, SR control.                                                                                  
2References the Saikali pig brain atlas which provides more detailed estimation of structures with in cortical regions (17). 
3Missing cluster value is contiguous with voxel cluster listed immediately above, and represents 1 of 2 continuous voxel clusters with 2 different center voxels. 
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Table 4.3. Comparison of grey matter cluster volumes between piglets fed T1 vs. T21 
Tissue Comparison Anatomic Region 
Cluster 
(voxels) 
Cluster level                      
(P-value) 
x y z Pseudo-t Saikali ROI2 
Gray Matter 
T1 > T2 
Right cortex 63 0.0062 13 -2 -7 3.44 Perihinal cortex 
Left cortex 29 0.0044 -20 -1 6 2.75 Inferior temporal gyrus 
Left cortex 38 0.0088 -19 7 6 2.61 Inferior temporal gyrus 
Left cortex 124 0.0078 -8 31 8 2.59 Dorsolateral prefrontal 
cortex Total voxels  254       
T2 > T1 
Left cortex 572 0.0006 -15 2 12 5.04  
Right cortex 822 0.0002 13 -2 17 4.09 Secondary visual cortex 
(V2) Right cortex 28 0.0074 15 3 10 3.83  
Right cortex 293 0.0004 13 10 2 3.57 Amygdala 
Undefined 351 0.0096 1 15 1 3.17  
Thalamus3  0.0090 1 3 2 2.3 Mediodorsal thalamic 
nucleus Undefined 26 0.0096 -10 11 1 2.33  
Total voxels 2092       
White Matter 
T1 > T2 Right cortex 124 0.0042 11 6 20 1.33 Somatosensory association 
cortex 
T2 > T1 
Left cortex 405 0.0006 -13 4 13 3.41  
Left cortex 890 0.0018 -12 4 -10 3.39  
Right cortex 340 0.0078 17 10 1 3.22  
Right cortex 30 0.0072 5 10 17 3.05 Premotor cortex 
Left cortex 86 0.0076 -4 10 16 3.04 Dorsal posterior cingular 
cortex Thalamus 227 0.0032 -8 -3 1 2.73  
Thalamus 33 0.006 0 2 4 2.22 Third ventricle 
Undefined 33 0.005 10 -3 1 2.17  
Right cortex 305 0.0076 16 -14 3 2.03 Crus 2 of the ansiform 
lobule Left cortex 68 0.0094 -15 10 1 1.98 Amygdala 
Left cortex3  0.0084 -18 1 -6 1.77 Parahippocampal cortex 
Left cortex 101 0.0084 -11 -5 -6 1.7  
Total voxels 2518       
Clusters > 20 were included in analysis with threshold set at P < 0.01. 
1Experimental Treatments include T1, AR control; T2, PDF.  
2References the Saikali pig brain atlas which provides more detailed estimation of structures with in cortical regions (17). 
3Missing cluster value is contiguous with voxel cluster listed immediately above, and represents 1 of 2 continuous voxel clusters with 2 different center 
voxels. 
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Table 4.4. Comparison of grey matter cluster volumes between piglets fed T1 vs. T31 
Tissue Comparison Anatomic Region 
Cluster 
(voxels) 
Cluster level                      
(P-value) 
x y z Pseudo-t Saikali ROI2 
Gray Matter 
T1 > T3 
Right cortex 20 0.0066 15 22 7 1.73 Insular cortex 
Medulla 37 0.0046 6 -17 -13 1.7 Facial nucleus 
Total voxels 57       
T3 > T1 
Left cortex 36 0.0056 -12 7 13 3.01  
Right cortex 755 0.0032 16 1 17 2.78  
Right cortex3  0.0098 19 -8 10 2.13 Superior temporal gyrus 
Thalamus 56 0.0090 -3 7 -2 1.36 Ventral anterior thalamic 
nucleus Cerebellum 241 0.0092 -11 -19 -1 1.35  
Undefined 860 0.0092 5 -16 15 1.22 Parahippocampal cortex 
Left cortex 41 0.0080 -16 9 -3 0.89 Amygdala 
Total voxels 1989       
White 
Matter 
T1 > T3 
Pons 396 0.0004 -4 -6 -11 4.78  
Pons 33 0.0078 4 -7 -11 3.54  
Thalamus 33 0.0078 6 6 1 2.8 Ventral anterior thalamic 
nucleus Total voxels 462       
T3 > T1 
Left cortex 602 0.0012 -13 5 13 4.75  
Left cortex 310 0.0016 -8 22 11 4.47  
Right cortex 192 0.0084 17 24 10 3.02 Insular cortex 
Midbrain 131 0.0072 8 -1 -4 2.21  
Right cortex 143 0.0096 18 10 2 1.96  
Undefined 56 0.0078 -8 -4 1 1.93 Nucleus of the optic tract 
Right cortex 66 0.0098 17 -13 3 0.8  
Total voxels 1500       
Clusters > 20 were included in analysis with threshold set at P < 0.01. 
1Experimental Treatments include T1, AR control; T3, PDF + lecithin + cholesterol. 
2References the Saikali pig brain atlas which provides more detailed estimation of structures with in cortical regions (17). 
3Missing cluster value is contiguous with voxel cluster listed immediately above, and represents 1 of 2 continuous voxel clusters with 2 different center 
voxels. 
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Table 4.5. Comparison of grey matter cluster volumes between piglets fed T2 vs. T31 
Tissue Comparison 
Anatomic 
Region 
Cluster 
(voxels) 
Cluster level                      
(P-value) 
x y z Pseudo-t Saikali ROI2 
Gray Matter 
T2 > T3 Left cortex 49 0.007 -11 -8 -3 3.93  
T3 > T2 
Right cortex 242 0.0048 13 -3 -8 3.23  
Left cortex 104 0.0082 -8 29 9 2.81 Dorsolateral prefrontal cortex 
Left cortex 24 0.0082 -19 1 -6 1.71  
Total voxels 370       
White 
Matter 
T2 > T3 
Undefined 21 0.006 -5 -8 -8 2.19  
Right cortex 23 0.0098 11 -16 6 1.5 Cerebellar lobule VI 
Undefined 47 0.0092 2 -15 -11 1.32  
Undefined 31 0.0092 -7 10 -8 0.53  
Total voxels 122       
T3 > T2 Undefined 37 0.0094 -1 13 -9 0.23 Optic chiasm 
Clusters > 20 were included in analysis with threshold set at P < 0.01. 
1Experimental Treatments include T2, PDF; T3, PDF + lecithin + cholesterol.   
2 References the Saikali pig brain atlas which provides more detailed estimation of structures with in cortical regions (17). 
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Table 4.6. Absolute brain and region-specific volumes (mm3) for artificially-reared (AR) and sow-reared (SR) piglets1 
 Experimental Treatment2 P-value 
ROI3 T1 T2 T3 SR Reference Treatment Sex 
n 9 10 10 10   
WB 58292 ± 3571.1b 59019 ± 3498.3b 58831± 3498.3b 73199 ± 3491.2a <0.001 0.173 
GM 29767 ± 967.9b 30151 ± 942.7b 29116 ± 942.7b 34585 ± 940.2a <0.001 0.276 
WM 11100 ± 603.0b 11235 ± 590.9b 11121 ± 590.9b 13999 ± 589.7a <0.001 0.136 
LC 16309 ± 450.1b 16483 ± 440.9b 16293 ± 440.9b 18504 ± 440.0a <0.001 0.272 
RC 15412 ± 406.1b 15602 ± 397.5b 15414 ± 397.5b 17588 ± 396.6a <0.001 0.262 
LHP 566.2 ± 15.90b 582.4 ± 15.48b 573.5 ± 15.48b 626.7 ± 15.44a 0.002 0.978 
RHP 627.7 ± 20.10b 635.2 ± 19.57b 628.2 ± 19.57b 700.2 ± 19.51a 0.001 0.884 
CA 116.5 ± 3.56 116.7 ± 3.39 116.5 ± 3.39 118.3 ± 3.37 0.975 0.354 
CB 4570.0 ± 157.99b 4646.8 ± 155.05b 4525.1 ± 155.05b 5371.7 ± 154.77a <0.001 0.948 
CC 1041.0 ± 35.92b 1026.6 ± 35.04b 1030.6 ± 35.04b 1167.2 ± 34.95a <0.001 0.204 
CD 510.1 ± 18.04b 532.7 ± 17.64ab 521.6 ± 17.64ab 551.8 ± 17.60a 0.078 0.261 
FV 137.5 ± 3.79b 141.0 ± 3.65b 134.0 ± 3.65b 151.4 ± 3.63a 0.003 0.460 
HYP 523.9 ± 16.49b 531.3 ± 16.15b 531.8 ± 16.15b 601.8 ± 16.11a <0.001 0.420 
IC 4701.5 ± 195.10b 4753.6 ± 191.23b 4743.9 ± 191.23b 5641.1 ± 190.85a <0.001 0.158 
LV 1093.1 ± 34.92 1109.1 ± 33.34 1146.9 ± 33.34 1110.5 ± 33.18 0.685 0.928 
MB 2960.0 ± 82.88b 2988.0 ± 81.26b 2975.0 ± 81.26b 3318.0 ± 81.11a <0.001 0.588 
MED 2377.4 ± 72.05b 2407.0 ± 70.68b 2348.8 ± 70.68b 2744.0 ± 70.55a <0.001 0.503 
OB 2966.4 ± 74.69b 2942.3 ± 72.57b 2938.9 ± 72.57b 3332.5 ± 72.36a <0.001 0.278 
PN 845.1 ± 18.78b 854.0 ± 18.49b 846.7 ± 18.49b 918.6 ± 18.46a <0.001 0.539 
PUT 1127.5 ± 37.45b 1138.0  ± 36.56b 1124.4 ± 36.56b 1301.0 ± 36.47a <0.001 0.115 
TH 2941.9 ± 78.81b 2996.3 ± 76.89b 2940.2 ± 76.89b 3339.6 ± 76.70a <0.001 0.242 
TV 199.5 ± 5.59 213.2 ± 5.39 207.6 ± 5.39 215.7 ± 5.37 0.072 0.644 
a-bMeans within a row lacking a common superscript letter differ (P < 0.05). 
1Values are presented as means ± SEM.  
2Experimental Treatments include AR (T1-T3) and SR groups. T1, AR control; T2, PDF; T3, PDF + lecithin + cholesterol; T4, SR control.                                                                                  
3Abbreviations: ROI, region of interest; WB, whole brain; GM, grey matter; WM, white matter; AC, average cortex; LC, left cortex; RC, right cortex; AHP, average 
hippocampi; LHP, left hippocampus; RHP, right hippocampus; CA, cerebral aqueduct; CB, cerebellum; CC, corpus callosum; CD, caudate; FV, fourth ventricle; HYP, 
hypothalamus; IC, internal capsule; LV, lateral ventricle; MB, midbrain; MED, medulla; OB, olfactory bulb; PN, pons; PUT, putamen; TH, thalamus; TV, third ventricle.  
 
 109 
 
 
Table 4.7. Region-specific relative volumes for artificially-reared (AR) and sow-reared (SR) piglets1 
 % TBV2 
 Experimental Treatment3 P-value 
ROI4 T1 T2 T3 SR Reference Treatment Sex 
n 9 10 10 10   
GM 51.31 ± 1.919 51.75 ± 1.854 49.57 ± 1.854 48.25 ± 1.848 0.326  0.034 
WM 19.09 ± 0.764 19.18 ± 0.733 18.94 ± 0.733 19.43 ± 0.730 0.957  0.013 
LC 28.16 ± 0.985 28.26 ± 0.956 27.79 ± 0.956 25.80 ± 0.954 0.060 0.028 
RC 26.63 ± 0.952 26.75 ± 0.925 26.30 ± 0.925 24.53 ± 0.922 0.089 0.031 
LHP 0.98 ± 0.040a 1.00 ± 0.039a 0.98 ± 0.039a 0.87 ± 0.039b 0.011 0.240 
RHP 1.09 ± 0.044a 1.09 ± 0.043a 1.07 ± 0.043a 0.97 ± 0.043b 0.020  0.128 
CA 0.20 ± 0.011a 0.20 ± 0.011a 0.20 ± 0.011a 0.17 ± 0.011b <0.001 0.647 
CB 7.88 ± 0.262 7.96 ± 0.252 7.71 ± 0.252 7.47 ± 0.251 0.387  0.113 
CC 1.80 ± 0.069 1.76 ± 0.067 1.76 ± 0.067 1.62 ± 0.067 0.077  0.019 
CD 0.88 ± 0.040a 0.92 ± 0.039a 0.89 ± 0.039a 0.77 ± 0.039b 0.002 0.051 
FV 0.24 ± 0.012a 0.24 ± 0.012a 0.23 ± 0.012ab 0.21 ± 0.012b 0.040  0.520 
HYP 0.91 ± 0.039 0.91 ± 0.038 0.91 ± 0.038 0.84 ± 0.038 0.125  0.054 
IC 8.10 ± 0.322 8.15 ± 0.310 8.09 ± 0.310 7.85 ± 0.309 0.823  0.026 
LV 1.90 ± 0.115a 1.91 ± 0.112a 1.97 ± 0.112a 1.55 ± 0.112b <0.001  0.407 
MB 5.12 ± 0.188a 5.12 ± 0.183a 5.08 ± 0.183a 4.62 ± 0.183b 0.022  0.070 
MED 4.10 ± 0.149 4.13 ± 0.144 4.01 ± 0.144 3.83 ± 0.143 0.271 0.076 
OB 5.13 ± 0.176 5.04 ± 0.171 5.01 ± 0.171 4.65 ± 0.170 0.074  0.029 
PN 1.46 ± 0.059a 1.47 ± 0.058a 1.45 ± 0.058a 1.29 ± 0.057b 0.010  0.116 
PUT 1.95 ± 0.081 1.96 ± 0.078 1.92 ± 0.078 1.81 ± 0.078 0.305 0.023 
TH 5.09 ± 0.206 5.15 ± 0.200 5.02 ± 0.200 4.66 ± 0.200 0.097  0.051 
TV 0.35 ± 0.016a 0.37 ± 0.016a 0.36 ± 0.016a 0.30 ± 0.016b <0.001  0.283 
a-bMeans within a row lacking a common superscript letter differ (P < 0.05). 
1Values are presented as means ± SEM.  
2Percent total brain volume (% TBV) was calculated by dividing ROI absolute volume by total brain absolute volume. 
3Experimental Treatments include AR (T1-T3) and SR groups. T1, AR control; T2, PDF; T3, PDF + lecithin + cholesterol; T4, SR control.                                                                                  
4Abbreviations: ROI, region of interest; WB, whole brain; GM, grey matter; WM, white matter; AC, average cortex; LC, left cortex; RC, right cortex; AHP, average 
hippocampi; LHP, left hippocampus; RHP, right hippocampus; CA, cerebral aqueduct; CB, cerebellum; CC, corpus callosum; CD, caudate; FV, fourth ventricle; HYP, 
hypothalamus; IC, internal capsule; LV, lateral ventricle; MB, midbrain; MED, medulla; OB, olfactory bulb; PN, pons; PUT, putamen; TH, thalamus; TV, third ventricle.  
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Table 4.8. Average fractional anisotropy (FA) values for artificially-reared (AR) and sow-reared (SR) piglets1   
 Experimental Treatment2 P-value 
Brain Region3 T1 T2 T3 SR Reference Treatment Sex 
n 9 10 9 9   
WB 0.299 ± 0.002b 0.301 ± 0.002b 0.300 ± 0.002b 0.308 ± 0.002a 0.008 0.679 
WM 0.299 ± 0.002b 0.299 ± 0.002b 0.299 ± 0.002b 0.309 ± 0.002a 0.001 0.451 
CC 0.280 ± 0.006 0.274 ± 0.006 0.276 ± 0.006 0.285 ± 0.006 0.573 0.357 
IC 0.383 ± 0.008b 0.379 ± 0.007b 0.390 ± 0.008ab 0.412 ± 0.008a 0.021 0.130 
TH 0.311 ± 0.005 0.306 ± 0.005 0.313 ± 0.005 0.321 ± 0.005 0.216 0.739 
LC 0.299 ± 0.005 0.292 ± 0.005 0.296 ± 0.005 0.311 ± 0.005 0.077 0.775 
RC 0.298 ± 0.002b 0.298 ± 0.002b 0.299 ± 0.002b 0.308 ± 0.002a 0.008 0.958 
LHP 0.271 ± 0.007 0.269 ± 0.007 0.270 ± 0.007 0.278 ± 0.007 0.759 0.120 
RHP 0.264 ± 0.006 0.271 ± 0.006 0.281 ± 0.006 0.273 ± 0.006 0.279 0.077 
a-bMeans within a row lacking a common superscript letter differ (P < 0.05). 
1Values are presented as means ± SEM. 
2Experimental Treatments include AR (T1-T3) and SR groups. T1, AR control; T2, PDF; T3, PDF + lecithin + cholesterol; T4, SR control.                                                                                  
3Abbreviations: WB, whole brain; WM, white matter; CC, corpus callosum; IC, internal capsule; TH, thalamus; AHP, average hippocampi; LC, left cortex; 
RC, right cortex; LHP, left hippocampus; RHP, right hippocampus. 
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Table 4.9. Axial diffusivity (AD) values for artificially-reared (AR) and sow-reared (SR) piglets1   
 Experimental Treatment2 P-value 
Brain Region3 T1 T2 T3 SR Reference Treatment Sex 
n 9 10 9 9   
WB 1.38 ± 0.024a 1.38 ± 0.023a 1.38 ± 0.024a 1.34 ± 0.024b 0.007 0.295 
WM 1.34 ± 0.023 1.33 ± 0.023 1.32 ± 0.023 1.31 ± 0.023 0.372 0.836 
CC 1.65 ± 0.056 1.61 ± 0.053 1.59 ± 0.056 1.57 ± 0.056 0.754 0.892 
IC 1.26 ± 0.011ab 1.24 ± 0.011b 1.26 ± 0.011ab 1.29 ± 0.011a 0.032 0.428 
TH 1.24 ± 0.026 1.21 ± 0.025 1.22 ± 0.026 1.25 ± 0.026 0.563 0.241 
LC 1.35 ± 0.034 1.39 ± 0.032 1.32 ± 0.033 1.32 ± 0.033 0.247 0.487 
RC 1.33 ± 0.019 1.31 ± 0.019 1.32 ± 0.019 1.31 ± 0.019 0.328 0.771 
LHP 1.46 ± 0.068 1.42 ± 0.066 1.43 ± 0.068 1.42 ± 0.068 0.905 0.893 
RHP 1.39 ± 0.059 1.32 ± 0.057 1.38 ± 0.059 1.40 ± 0.059 0.749 0.028 
a-bMeans within a row lacking a common superscript letter differ (P < 0.05). 
1Values are presented as means ± SEM × 1000. 
2Experimental Treatments include AR (T1-T3) and SR groups. T1, AR control; T2, PDF; T3, PDF + lecithin + cholesterol; T4, SR control.                                                                                  
3Abbreviations: WB, whole brain; WM, white matter; CC, corpus callosum; IC, internal capsule; TH, thalamus; AHP, average hippocampi; LC, left cortex; 
RC, right cortex; LHP, left hippocampus; RHP, right hippocampus.                                                                                
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Table 4.10. Mean diffusivity (MD) values for artificially-reared (AR) and sow-reared (SR) piglets1   
 Experimental Treatment2 P-value 
Brain Region3 T1 T2 T3 SR Reference Treatment Sex 
n 9 10 9 9   
WB 1.05 ± 0.020a 1.05 ± 0.020a 1.04 ± 0.020a 1.01 ± 0.020b 0.007 0.367 
WM 1.01 ± 0.020 1.01 ± 0.019 1.00 ± 0.020 0.98 ± 0.020 0.200 0.743 
CC 1.27 ± 0.039 1.25 ± 0.037 1.23 ± 0.039 1.21 ± 0.039 0.698 0.866 
IC 0.88 ± 0.006 0.87 ± 0.006 0.87 ± 0.006 0.87 ± 0.006 0.750 0.580 
TH 0.92 ± 0.016 0.90 ± 0.015 0.91 ± 0.016 0.92 ± 0.016 0.696 0.231 
LC 1.02 ± 0.030 1.07 ± 0.028 1.00 ± 0.030 0.99 ± 0.030 0.200 0.463 
RC 1.01 ± 0.016 0.99 ± 0.016 1.00 ± 0.016 0.98 ± 0.016 0.134 0.819 
LHP 1.13 ± 0.054 1.10 ± 0.053 1.10 ± 0.054 1.09 ± 0.054 0.876 0.663 
RHP 1.07 ± 0.044 1.07 ± 0.042 1.06 ± 0.044 1.08 ± 0.044 0.704 0.049 
a-bMeans within a row lacking a common superscript letter differ (P < 0.05). 
1Values are presented as means ± SEM × 1000. 
2Experimental Treatments include AR (T1-T3) and SR groups. T1, AR control; T2, PDF; T3, PDF + lecithin + cholesterol; T4, SR control. 
3Abbreviations: WB, whole brain; WM, white matter; CC, corpus callosum; IC, internal capsule; TH, thalamus; AHP, average hippocampi; LC, left cortex; 
RC, right cortex; LHP, left hippocampus; RHP, right hippocampus. 
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Table 4.11. Radial diffusivity (RD) values for artificially-reared (AR) and sow-reared (SR) piglets1   
 Experimental Treatment2 P-value 
Brain Region3 T1 T2 T3 SR Reference Treatment Sex 
n 9 10 9 9   
WB 0.88 ± 0.019a 0.88 ± 0.019a 0.88 ± 0.019a 0.84 ± 0.019b 0.008 0.421 
WM 0.85 ± 0.018 0.85 ± 0.018 0.84 ± 0.018 0.82 ± 0.018 0.129 0.697 
CC 1.08 ± 0.031 1.06 ± 0.029 1.05 ± 0.031 1.02 ± 0.031 0.638 0.661 
IC 0.69 ± 0.007 0.68 ± 0.007 0.68 ± 0.007 0.66 ± 0.007 0.109 0.164 
TH 0.77 ± 0.012 0.75 ± 0.011 0.75 ± 0.012 0.76 ± 0.012 0.701 0.268 
LC 0.86 ± 0.028 0.91 ± 0.027 0.84 ± 0.028 0.82 ± 0.028 0.175 0.457 
RC 0.85 ± 0.015 0.84 ± 0.015 0.84 ± 0.015 0.82 ± 0.015 0.070 0.849 
LHP 0.96 ± 0.048 0.94 ± 0.047 0.94 ± 0.048 0.92 ± 0.048 0.833 0.403 
RHP 0.91 ± 0.037 0.87 ± 0.035 0.90 ± 0.037 0.93 ± 0.037 0.665 0.080 
a-bMeans within a row lacking a common superscript letter differ (P < 0.05). 
1Values are presented as means ± SEM × 1000. 
2Experimental Treatments include AR (T1-T3) and SR groups. T1, AR control; T2, PDF; T3, PDF + lecithin + cholesterol; T4, SR control. 
3Abbreviations: WB, whole brain; WM, white matter; CC, corpus callosum; IC, internal capsule; TH, thalamus; AHP, average hippocampi; LC, left cortex; 
RC, right cortex; LHP, left hippocampus; RHP, right hippocampus. 
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Table 4.12. Absolute hippocampal metabolite concentrations for artificially-reared (AR) and sow-reared (SR) piglets1 
 Experimental Treatment
2 P-value 
Metabolite3 T1 T2 T3 SR Reference Treatment Sex 
n 5-9 5-10 4-9 5-8   
CR 2.97 ± 0.225 3.24 ± 0.246 3.87 ± 0.296 3.06 ± 0.277 0.142 0.236 
CR + PCR 3.32 ± 0.159b 3.40 ± 0.152b 3.68 ± 0.150b 4.23 ± 0.160a 0.002 0.709 
GLU 6.06 ± 0.492 5.49 ± 0.459 5.61 ± 0.492 5.30 ± 0.598 0.635 0.006 
GLU+ GLN 10.21 ± 0.766 8.97 ± 0.698 9.25 ± 0.728 7.43 ± 0.775 0.074 0.018 
GPC + PCH 1.25 ± 0.075bc 1.14 ± 0.068c 1.45 ± 0.071b 1.66 ± 0.076a <0.001 0.216 
GSH 2.04 ± 0.361 2.50 ± 0.377 2.47 ± 0.327 2.31 ± 0.377 0.796 0.531 
INS 7.67 ± 0.414b 7.70 ± 0.383b 8.76 ± 0.397a 9.54 ± 0.419a 0.001 0.519 
NAA 4.70 ± 0.272 4.51 ± 0.262 5.18 ± 0.259 5.00 ± 0.276 0.224 0.745 
NAA + NAAG 5.12 ± 0.206bc 4.91 ± 0.198c 5.78 ± 0.196a 5.69 ± 0.209ab 0.008 0.693 
a-cMeans within a row lacking a common superscript letter differ (P < 0.05). 
1Values are presented as means ± SEM. Single voxel MRS for metabolites met criteria for analysis (less than 20% standard deviation) and were detected in at 
least 4 pigs per treatment. 
2Experimental Treatments include AR (T1-T3) and SR groups. T1, AR control; T2, PDF; T3, PDF + lecithin + cholesterol; T4, SR control. 
3Abbreviations: CR, creatine; CR + PCR, creatine + phosphocreatine; GLU, glutamate; GLU+ GLN, glutamate + glutamine; GPC + PCH, 
glycerophosphocholine + phosphocholine; GSH, glutothione; INS, myo-inositol; NAA, N-acetylaspartate; NAA + NAAG, N-acetylaspartate + N-
acetylaspartylglutamate. 
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Figures 
Artificially-reared (AR) vs. sow-reared (SR) 
 
 
 
Figure 4.1. Voxel-based morphometric analysis of white and grey matter volume differences between the average of artificially-
reared (AR) (T1, T2, and T3) and sow-reared (SR) piglets. Clusters less than 20 voxels and found on the edge of the brain were 
excluded from the analysis, and height threshold was set at P = 0.001. A) Voxel clusters in which AR > SR in grey matter volume; B) 
Voxel clusters in which AR > SR in white matters volume C) Voxel clusters in which SR > AR in grey matter volume; D) Voxel 
clusters in which SR > AR in white matter volume. Experimental Treatments include (n=9-10) T1, AR control; T2, PDF; T3, PDF + 
lecithin + cholesterol; T4, SR control. 
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T1 vs. T2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
D C 
A 
Figure 4.2. Voxel-based morphometric analysis of white and grey matter volume differences between treatments T1 and T2. Voxel 
clusters < 20 and found on the edge of the brain were removed. Height threshold was set at P = 0.01. A) Voxel clusters in which T1 > T2 
in grey matter volume; B) Voxel clusters in which T1 > T2 in white matter volume; C) Voxel clusters in which T2 > T1 in grey matter 
volume; D) Voxel clusters in which T2 > T1 in white matter volume. Experimental Treatments include (n=9-10) T1, AR control; T2, 
PDF. 
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 T1 vs. T3 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Voxel based morphometric analysis of white and grey matter volume differences between treatments T1and T3. Voxel 
clusters < 20 and found on the edge of the brain were removed. Height threshold was set at P = 0.01. A) Voxel clusters in which T1 
> T3 in grey matter volume; B) Voxel clusters in which T1 > T3 in white matter volume; C) Voxel clusters in which T3 > T1 in grey 
matter volume; D) Voxel clusters in which T3 > T1 in white matter volume. Experimental Treatments include (n=9-10) T1, AR 
control; T3, PDF + lecithin + cholesterol. 
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T2 vs. T2
C
 
Figure 4.4. Voxel based morphometric analysis of white and grey matter volume differences between treatments T2 and T3. Voxel 
clusters < 20 and found on the edge of the brain were removed. Height threshold was set at P = 0.01. A) Voxel clusters in which T2 > T3 
in grey matter volume; B) Voxel clusters in which T2 > T3 in white matter volume; C) Voxel clusters in which T3 > T2 in grey matter 
volume; D) Voxel clusters in which T3 > T2 in white matter volume. Experimental Treatments include (n=9-10) T2, PDF; T3, PDF + 
lecithin + cholesterol. 
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Chapter 5 
SUMMARY AND SIGNIFICANCE 
 
The world health organization recommends up to 6 months of exclusive breast feeding 
for infants, but there are often circumstances where combined breast and formula feeding or 
formula feeding alone would be provided to a child. Therefore, it is critical that scientific efforts 
focus on characterizing the complete composition of maternal milk, and thereby strive to mimic 
this matrix in infant formula. Of particular interest is docosahexaenoic acid (DHA), an n-3, long 
chain polyunsaturated fatty acid (LCPUFA) that is naturally enriched in breast milk. Although 
not considered an essential fatty acid, DHA has been shown to have potent effects in terms of 
supporting the developing infant brain (1,2). Particularly, DHA is incorporated heavily in 
glycerophospholipid moieties, which make the up the plasma membrane of neurons and may 
have notable influence on white matter maturation, signal conduction, and other important 
processes (3). As dietary triglycerides serves as the primary carrier for essential and non-
essential fatty acids in milk, the characterization and supplementation of such fatty acids (FA) 
has been underway since the 1980s, yet incorporation of DHA into infant formula only began in 
2002. Despite the addition of preformed DHA in infant formula, the breast fed infant’s ability to 
absorb dietary lipid remain higher than that of the formula-fed infants (4). Greater absorption of 
LCPUFA, such as DHA, has often been hypothesized to enhanced brain development and 
cognitive outcomes in the breast fed infants as compared with their formula-fed counterparts 
(4,5). This leads us to believe that not only the composition, but the positional specificity with 
which dietary FA are incorporated into dietary triglycerides, as well as the addition of exogenous 
emulsifiers, can modulate the absorption, transport and incorporation of these FA into the brain. 
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Projects contained in this thesis were designed with the broad goal of minimizing the 
knowledge gap in our understanding of the lipid matrix present in formula and maternal milk. 
Using the piglet as a model for the human infant, our goal was to assess the impact of altering the 
lipid matrix found in infant formula on incorporation of DHA into the developing brain, and to 
characterize any subsequent alterations in neurodevelopment of the neonatal brain, as assessed 
by magnetic resonance imaging (MRI) techniques. We sought not only to elucidate the impact of 
varying lipid profiles on brain development in artificially-reared (AR) piglets, but to also 
generate a conspecific positive control using the sow-reared (SR) piglet. The sow-reared piglet 
served as an equivalent to the breast-fed infant, while the artificially-reared piglet was considered 
equivalent to the formula-fed infant. As such, AR piglets were fed 1 of 3 isocaloric dietary 
treatments as follows: T1, AR control formula; T2, T1 + 45% total dietary fat replaced with pre-
digested fat (PDF); T3, T2 + 10% lecithin + 0.4% cholesterol. Sow-reared piglets (T4) remained 
with their respective mother and litter mates for the duration for the study. Growth performance 
and metabolic outcomes were also assessed to further understand the impact of modifying the 
dietary lipid matrix on lipid metabolism and transport of dietary fat into neural tissue. However, 
we will focus mainly on the correlations between MRI outcomes, serum lipid profiles, as well as 
quantification of DHA in hippocampal tissue and red blood cells (RBC).  
 Of the multiple MRI sequences employed to assess neurodevelopment, diffusion tensor 
imaging (DTI), which assesses brain microstructure, was of particular interest. Importantly, DTI 
measures the diffusion of free water molecules with the axonal tracts of the developing neuron. 
Fractional anisotropy (FA) values are calculated from these diffusion outcomes, and provide a 
numerical range of 0-1 to describe the degree water insulation within the neuronal axon. 
Fractional anisotropy values that are closer to 1 suggest anisotropic movement of water 
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molecules, and suggest greater white matter maturation and myelination of axonal tracts. Global 
assessment of  white matter maturity, as assessed by FA values revealed higher FA values in the 
SR animals as compared with all AR animals, with no differences in whole-brain FA values 
being present between AR animals. These data suggest that the maternally-reared piglets 
possessed higher levels of myelination and white matter maturation as compared with the 
formula-fed piglets. However, region-specific assessment of white matter maturity in the internal 
capsule (IC) revealed that the addition of lecithin and cholesterol to the PDF system allowed for 
comparable levels of myelination to be present in T3 and SR piglets. This finding was quite 
exciting because the IC begins its maturation during gestation, and is therefore one of the 
primary regions to myelinate early in the postnatal period (6). Considering piglets underwent 
MRI procedures at a time of rapid brain development, we expected the neurodevelopmental 
trajectories observed in the IC to be prevalent to the whole-brain, or other regions of interest, as 
further maturation of the brain occurred.   
The role of cholesterol in synthesis of myelin is well established (7). However, few 
studies have linked the influence of dietary or circulating cholesterol to outcomes related to brain 
development. In fact, the cerebrum is hypothesized to generate all necessary cholesterol in situ 
(8).  However, the correlation between breast feeding and improved myelination of the neonatal 
brain is undeniable (9). Considering that breast milk is enriched in cholesterol, the literature does 
acknowledge the possibility of some transport of dietary cholesterol into the brain (10,11). 
Characterization of serum cholesterol revealed that SR animals possessed higher circulating 
serum cholesterol. However, the addition of cholesterol and lecithin to the PDF system elicited 
higher circulating cholesterol concentrations in T3 animals when compared with other 
artificially-reared treatment groups. These data suggest the PDF system allowed for more 
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efficacious absorption of dietary lipids, including cholesterol, into circulation. However, it may 
be the addition of lecithin plus cholesterol to the PDF system that allowed for greater 
incorporation of dietary cholesterol into the brain, and subsequent improvements in myelination 
observed in the IC. Verification of this hypothesis requires further analysis of brain cholesterol in 
the IC, as well as tracking of dietary cholesterol through all stages of digestion, absorption, 
circulation, and transport.  
Quantification of DHA in the phospholipid (PL) and neutral lipid (NL) fractions of tissue 
revealed that DHA is preferentially incorporated in to the PL fraction. Piglets fed PDF-
containing diets experienced a numerical increase in RBC DHA concentration as compared with 
control animals. However, the addition of lecithin and cholesterol resulted in a reduction of PL 
bound DHA in RBC to levels similar to that of the SR reference and control treatment. This 
reduction was unexpected, as RBC bound DHA is often associated with an increase in brain 
DHA in clinical trials (12). However, we observed that combination of lecithin and cholesterol 
with the PDF system allowed for greatest incorporation of DHA in hippocampal tissue, thereby 
achieving levels that were 2-fold higher than were detected in SR reference animals. We 
hypothesize that the reduction of RBC bound DHA in T3-fed piglets and subsequent increase in 
hippocampal DHA may be related. The addition of lecithin may be allowing for preferential 
binding of DHA to transporters (e.g., albumin), which allowed for more efficient transport of 
these FA beyond the blood brain endothelium. Although we were not able to assess DHA 
concentrations in the IC directly, the influence of DHA to maintain integrity of neurons and 
neural tissue has previously been established (1,13,14). Further analysis, including quantification 
of DHA within the IC of AR and SR animals, is necessary to associate the augmented accretion 
of DHA in the hippocampus with structural (i.e., maturational) benefits in the brain.  
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Overall, this project has generated insight into the impact of infant formula and maternal 
milk on postnatal brain development. As the full representation and replication of maternal milk 
in formula is far from complete, the data presented in this thesis provide a means to improve the 
bioavailability of one of the most conditionally essential FA found in infant formula. Our data 
suggest the addition of lecithin and cholesterol to the PDF system increases serum cholesterol, 
augments accretion of DHA in the phospholipid fraction of hippocampal tissue, and mediates 
greater myelination of axonal tracts in the IC as determined by FA values. To our knowledge, 
this study is also the first of its kind to characterize neurodevelopment of the SR piglet in its 
effort to establish a conspecific comparison for AR piglets. Suggested future directions for this 
research include a longer timeline where a subset of the animals are imaged and their tissue 
sampled at sexual maturity, as well as quantification of cholesterol and DHA in the same brain 
regions assessed for MRI outcomes. Finally, behavioral assessment to characterize the cognitive 
benefits of altering the lipid matrix of infant formula is also recommended to extend our 
findings. Ultimately, the pre-clinical evidence established in this study will pave the way for 
further clinical applications of these infant formulas, and suggested possibilities for nutrient 
based strategies to modulate the development of the central nervous system. 
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